JPH0153669B2 - - Google Patents
Info
- Publication number
- JPH0153669B2 JPH0153669B2 JP57068566A JP6856682A JPH0153669B2 JP H0153669 B2 JPH0153669 B2 JP H0153669B2 JP 57068566 A JP57068566 A JP 57068566A JP 6856682 A JP6856682 A JP 6856682A JP H0153669 B2 JPH0153669 B2 JP H0153669B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- formula
- independently represent
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 84
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 64
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 30
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 25
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- -1 pyrrolidino, morpholino, piperazinyl Chemical group 0.000 claims abstract description 18
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 15
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims abstract description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 10
- 150000001412 amines Chemical class 0.000 claims abstract description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- 229910005965 SO 2 Inorganic materials 0.000 claims description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 229910052794 bromium Inorganic materials 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 7
- SXVWPPJHFOCGAD-UHFFFAOYSA-N 2,4,5-trimethoxyaniline Chemical compound COC1=CC(OC)=C(OC)C=C1N SXVWPPJHFOCGAD-UHFFFAOYSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 150000004982 aromatic amines Chemical class 0.000 claims description 5
- 125000004429 atom Chemical group 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- JBXKXTUOGQNIKA-UHFFFAOYSA-N 2,4-dimethoxy-5-propylsulfonylaniline Chemical compound CCCS(=O)(=O)C1=CC(N)=C(OC)C=C1OC JBXKXTUOGQNIKA-UHFFFAOYSA-N 0.000 claims description 4
- KNCAXTCRDVWMBP-UHFFFAOYSA-N 2,4-dimethoxy-5-methylsulfonylaniline Chemical compound COC1=CC(OC)=C(S(C)(=O)=O)C=C1N KNCAXTCRDVWMBP-UHFFFAOYSA-N 0.000 claims description 3
- GEQNZVKIDIPGCO-UHFFFAOYSA-N 2,4-dimethoxyaniline Chemical compound COC1=CC=C(N)C(OC)=C1 GEQNZVKIDIPGCO-UHFFFAOYSA-N 0.000 claims description 3
- WRXNJTBODVGDRY-UHFFFAOYSA-N 2-pyrrolidin-1-ylethanamine Chemical compound NCCN1CCCC1 WRXNJTBODVGDRY-UHFFFAOYSA-N 0.000 claims description 3
- YYAYTNPNFKPFNG-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)propan-1-amine Chemical compound CC1CCCCN1CCCN YYAYTNPNFKPFNG-UHFFFAOYSA-N 0.000 claims description 3
- JMUCXULQKPWSTJ-UHFFFAOYSA-N 3-piperidin-1-ylpropan-1-amine Chemical compound NCCCN1CCCCC1 JMUCXULQKPWSTJ-UHFFFAOYSA-N 0.000 claims description 3
- MNCWCTCUSSOSKJ-UHFFFAOYSA-N 5-bromo-2,4-dimethoxyaniline Chemical compound COC1=CC(OC)=C(Br)C=C1N MNCWCTCUSSOSKJ-UHFFFAOYSA-N 0.000 claims description 3
- OLCMNCWEUMBNIS-UHFFFAOYSA-N 5-chloro-2,4-dimethoxyaniline Chemical compound COC1=CC(OC)=C(Cl)C=C1N OLCMNCWEUMBNIS-UHFFFAOYSA-N 0.000 claims description 3
- OQWNBEFBVLHPFA-UHFFFAOYSA-N 5-ethylsulfonyl-2,4-dimethoxyaniline Chemical compound CCS(=O)(=O)C1=CC(N)=C(OC)C=C1OC OQWNBEFBVLHPFA-UHFFFAOYSA-N 0.000 claims description 3
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 claims description 3
- UDGSVBYJWHOHNN-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine Chemical compound CCN(CC)CCN UDGSVBYJWHOHNN-UHFFFAOYSA-N 0.000 claims description 3
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 claims description 3
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 claims description 3
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims 5
- CJNRGSHEMCMUOE-UHFFFAOYSA-N 2-piperidin-1-ylethanamine Chemical compound NCCN1CCCCC1 CJNRGSHEMCMUOE-UHFFFAOYSA-N 0.000 claims 2
- UIKUBYKUYUSRSM-UHFFFAOYSA-N 3-morpholinopropylamine Chemical compound NCCCN1CCOCC1 UIKUBYKUYUSRSM-UHFFFAOYSA-N 0.000 claims 2
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 abstract description 6
- 150000002367 halogens Chemical class 0.000 abstract description 6
- 150000007522 mineralic acids Chemical class 0.000 abstract description 5
- 150000007524 organic acids Chemical class 0.000 abstract description 5
- 150000003840 hydrochlorides Chemical class 0.000 abstract description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 6
- 239000000243 solution Substances 0.000 description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000000203 mixture Substances 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000003760 magnetic stirring Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- DPZNOMCNRMUKPS-UHFFFAOYSA-N 1,3-Dimethoxybenzene Chemical compound COC1=CC=CC(OC)=C1 DPZNOMCNRMUKPS-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- 239000012429 reaction media Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 6
- 150000008331 benzenesulfonamides Chemical class 0.000 description 6
- 239000001110 calcium chloride Substances 0.000 description 6
- 229910001628 calcium chloride Inorganic materials 0.000 description 6
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 6
- 235000011121 sodium hydroxide Nutrition 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000012954 diazonium Substances 0.000 description 5
- 229960001412 pentobarbital Drugs 0.000 description 5
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- AYGZKRRIULCJKC-UHFFFAOYSA-N 2,4-dimethoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C(OC)=C1 AYGZKRRIULCJKC-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- JTVPZMFULRWINT-UHFFFAOYSA-N N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide Chemical compound CCN(CC)CCNC(=O)C1=CC(S(C)(=O)=O)=CC=C1OC JTVPZMFULRWINT-UHFFFAOYSA-N 0.000 description 4
- UNRHXEPDKXPRTM-UHFFFAOYSA-N Sultopride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)CC)=CC=C1OC UNRHXEPDKXPRTM-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 150000001989 diazonium salts Chemical class 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000004622 sleep time Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- LSFOYENWQJZHKY-UHFFFAOYSA-N 2,4,5-trimethoxybenzenesulfonyl chloride Chemical compound COC1=CC(OC)=C(S(Cl)(=O)=O)C=C1OC LSFOYENWQJZHKY-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000935 antidepressant agent Substances 0.000 description 3
- 229940005513 antidepressants Drugs 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 3
- 229960004724 sultopride Drugs 0.000 description 3
- 229960005344 tiapride Drugs 0.000 description 3
- BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 description 2
- AGIQIOSHSMJYJP-UHFFFAOYSA-N 1,2,4-Trimethoxybenzene Chemical compound COC1=CC=C(OC)C(OC)=C1 AGIQIOSHSMJYJP-UHFFFAOYSA-N 0.000 description 2
- NIUZVSQOXJIHBL-UHFFFAOYSA-N 1-bromo-2,4-dimethoxybenzene Chemical compound COC1=CC=C(Br)C(OC)=C1 NIUZVSQOXJIHBL-UHFFFAOYSA-N 0.000 description 2
- OACCRGFGCIQFNR-UHFFFAOYSA-N 1-chloro-2,4-dimethoxybenzene Chemical compound COC1=CC=C(Cl)C(OC)=C1 OACCRGFGCIQFNR-UHFFFAOYSA-N 0.000 description 2
- CPADFRBFGBIDQD-UHFFFAOYSA-N 1-chloro-4,5-dimethoxy-2-nitrobenzene Chemical compound COC1=CC(Cl)=C([N+]([O-])=O)C=C1OC CPADFRBFGBIDQD-UHFFFAOYSA-N 0.000 description 2
- MGHCDRVTMABICG-UHFFFAOYSA-N 2,4-dimethoxybenzenesulfonamide Chemical class COC1=CC=C(S(N)(=O)=O)C(OC)=C1 MGHCDRVTMABICG-UHFFFAOYSA-N 0.000 description 2
- RXJCXGJKJZARAW-UHFFFAOYSA-N 4-chloro-1,2-dimethoxybenzene Chemical compound COC1=CC=C(Cl)C=C1OC RXJCXGJKJZARAW-UHFFFAOYSA-N 0.000 description 2
- AHQXIQGOFUWTAS-UHFFFAOYSA-N 5-bromo-2,4-dimethoxybenzenesulfonyl chloride Chemical compound COC1=CC(OC)=C(S(Cl)(=O)=O)C=C1Br AHQXIQGOFUWTAS-UHFFFAOYSA-N 0.000 description 2
- HXTZVKXMOKCJPE-UHFFFAOYSA-N 5-chloro-2,4-dimethoxybenzenesulfonyl chloride Chemical compound COC1=CC(OC)=C(S(Cl)(=O)=O)C=C1Cl HXTZVKXMOKCJPE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010017600 Galactorrhoea Diseases 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- 230000000949 anxiolytic effect Effects 0.000 description 2
- ASGJEMPQQVNTGO-UHFFFAOYSA-N benzene chloroform Chemical compound C(Cl)(Cl)Cl.C1=CC=CC=C1.C1=CC=CC=C1 ASGJEMPQQVNTGO-UHFFFAOYSA-N 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 229910010271 silicon carbide Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- NVNPAMYRUFFLQJ-UHFFFAOYSA-M sodium;2,4-dimethoxybenzenesulfinate Chemical compound [Na+].COC1=CC=C(S([O-])=O)C(OC)=C1 NVNPAMYRUFFLQJ-UHFFFAOYSA-M 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 229960004940 sulpiride Drugs 0.000 description 2
- 239000003204 tranquilizing agent Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- SXVFZZZETDRISD-UHFFFAOYSA-N 1,2,4-trimethoxy-5-nitrobenzene Chemical compound COC1=CC(OC)=C([N+]([O-])=O)C=C1OC SXVFZZZETDRISD-UHFFFAOYSA-N 0.000 description 1
- HZNQSWJZTWOTKM-UHFFFAOYSA-N 2,3,4-trimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(OC)=C1OC HZNQSWJZTWOTKM-UHFFFAOYSA-N 0.000 description 1
- UGEHFOSBNBEWMP-UHFFFAOYSA-N 2,3-diaminobenzenesulfonic acid Chemical compound NC1=CC=CC(S(O)(=O)=O)=C1N UGEHFOSBNBEWMP-UHFFFAOYSA-N 0.000 description 1
- LGZZANCONWJHFV-UHFFFAOYSA-N 2,4-dimethoxy-5-methylsulfonylbenzenesulfonyl chloride Chemical compound COC1=CC(OC)=C(S(Cl)(=O)=O)C=C1S(C)(=O)=O LGZZANCONWJHFV-UHFFFAOYSA-N 0.000 description 1
- DXHONXPVRCLDKJ-UHFFFAOYSA-N 2,4-dimethoxy-5-propan-2-ylsulfonylaniline Chemical compound COC1=CC(OC)=C(S(=O)(=O)C(C)C)C=C1N DXHONXPVRCLDKJ-UHFFFAOYSA-N 0.000 description 1
- ITVVQEQMDNDAIL-UHFFFAOYSA-N 2,4-dimethoxy-5-propan-2-ylsulfonylbenzenesulfonyl chloride Chemical compound COC1=CC(OC)=C(S(=O)(=O)C(C)C)C=C1S(Cl)(=O)=O ITVVQEQMDNDAIL-UHFFFAOYSA-N 0.000 description 1
- SGHCKSQCWDKWGH-UHFFFAOYSA-N 2,4-dimethoxy-5-propylsulfonylbenzenesulfonyl chloride Chemical compound CCCS(=O)(=O)C1=CC(S(Cl)(=O)=O)=C(OC)C=C1OC SGHCKSQCWDKWGH-UHFFFAOYSA-N 0.000 description 1
- OTNHRMBTQWQKMB-UHFFFAOYSA-N 2,4-dimethoxybenzenesulfinic acid Chemical compound COC1=CC=C(S(O)=O)C(OC)=C1 OTNHRMBTQWQKMB-UHFFFAOYSA-N 0.000 description 1
- MRUDNSFOFOQZDA-UHFFFAOYSA-M 2,6-dichlorobenzoate Chemical compound [O-]C(=O)C1=C(Cl)C=CC=C1Cl MRUDNSFOFOQZDA-UHFFFAOYSA-M 0.000 description 1
- UENXVZUOFSZIHQ-UHFFFAOYSA-N 5-ethylsulfonyl-2,4-dimethoxybenzenesulfonyl chloride Chemical compound CCS(=O)(=O)C1=CC(S(Cl)(=O)=O)=C(OC)C=C1OC UENXVZUOFSZIHQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 208000001287 Galactorrhea Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229940005530 anxiolytics Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 208000018300 basal ganglia disease Diseases 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000003291 dopaminomimetic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- DOUHZFSGSXMPIE-UHFFFAOYSA-N hydroxidooxidosulfur(.) Chemical compound [O]SO DOUHZFSGSXMPIE-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- WQZXJTWTIYVJLT-UHFFFAOYSA-N n-ethylpiperidin-1-amine Chemical compound CCNN1CCCCC1 WQZXJTWTIYVJLT-UHFFFAOYSA-N 0.000 description 1
- GADIREFQKKSFKX-UHFFFAOYSA-N n-propylmorpholin-4-amine Chemical compound CCCNN1CCOCC1 GADIREFQKKSFKX-UHFFFAOYSA-N 0.000 description 1
- 229940105631 nembutal Drugs 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- XBRWSVCJOVWGQB-UHFFFAOYSA-M potassium;2,4-dimethoxybenzenesulfonate Chemical compound [K+].COC1=CC=C(S([O-])(=O)=O)C(OC)=C1 XBRWSVCJOVWGQB-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- FVIRGMIYFJWRGC-UHFFFAOYSA-N sulfurobromidic acid Chemical compound OS(Br)(=O)=O FVIRGMIYFJWRGC-UHFFFAOYSA-N 0.000 description 1
- BGRJTUBHPOOWDU-UHFFFAOYSA-N sulpiride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
æ¬çºæã¯ãæ°èŠãªïŒ®â眮æãã³ãŒã³ã¹ã«ãã³ã¢
ãã䞊ã³ã«ãã®å¡©ã«ä¿ããæ¬çºæã¯ãŸããããå
åç©ã®è£œæ³ã«ä¿ããæ¬çºæã¯æåŸã«ãããæ°èŠãª
â眮æãã³ãŒã³ã¹ã«ãã³ã¢ãã䞊ã³ã«è¬å€äžèš±
容ãããææ©åã¯ç¡æ©é žã«ãã€ãŠåŸãããåèšå
åç©ã®å¡©ãæå¹æåãšããŠå«æããæ°ããå»è¬ã«
ä¿ããæ¬çºæã«ããæ°ããâ眮æãã³ãŒã³ã¹ã«
ãã³ã¢ããã¯äžèšäžè¬åŒãæããã ãåŒäžã ïœåã³ïœã¯ããããïŒããïŒã®ããããã®å€ã§
ããã R3åã³R4ã¯ããããïŒä¹è³ïŒåã®ççŽ ååã
æããäœçŽã¢ã«ãã«åºãè¡šããã R1åã³R2ã¯ããããæ°ŽçŽ ååãïŒä¹è³ïŒåã®
ççŽ ååãæããçŽéåã¯åå²éã¢ã«ãã«åºãè¡š
ããããæãã¯çªçŽ ååãšçµåããŠïŒåã¯ïŒåã®
çµåïŒ1inkïŒãæããè€çŽ ç°åŒçªçŽ å«æåºãç¹ã«
ççŽ æ°ïŒä¹è³ïŒã®çŽéåã¯åå²éã¢ã«ãã«åºã«ã
ã眮æåã¯æªçœ®æã®ãããªãžãåºãã¢ã«ããªã
åºãããã©ãžãã«åºããããŒã«åºåã¯ãããªãžã
åºã圢æããŠããã R5ã¯æ°ŽçŽ ååãããã²ã³ãNO2ãNH2ãCF3ã
ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ã³ãã·åºåã¯
ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ãã«ã¹ã«ãã
ã«åºãè¡šããã R6åã³R7ã¯ããããæ°ŽçŽ ååãïŒä¹è³ïŒåã®
ççŽ ååãæããã¢ã«ãã«åºåã¯ïŒä¹è³ïŒåã®ç
çŽ ååãæããã·ã¯ãã¢ã«ãã«åºãè¡šããã æ¬çºæã¯ãè¬å€äžïŒphysiologicallyïŒèš±å®¹ã
ããææ©åã¯ç¡æ©é žãçšããŠåŸãããåŒïŒïŒã®
ååç©ã®ä»å å¡©ã«ãä¿ãã æ¬çºæã¯R7ãæ°ŽçŽ ååã§ãªãåŒïŒïŒã®åå
ç©äžŠã³ã«è¬å€äžèš±å®¹ãããææ©åã¯ç¡æ©é žãçšã
ãŠåŸãããåèšååç©ã®å¡©ã®å åŠç°æ§äœãã¹ãŠã«
é¢ããã è¬å€äžèš±å®¹ãããææ©åã¯ç¡æ©å¡©ãšããŠã¯ãã
ã€ããã¯ããªãããã€ãããããããç¡«é žå¡©ãç
é žå¡©ãã¡ã¿ã³ã¹ã«ãããŒããã¢ã»ããŒããããã¬
ãŒããã¹ã¯ã·ããŒããã©ã¯ããŒãããã«ããŒãã
ã·ãã¬ãŒãããã¿ãŒãã¬ãŒãããã¬ãšãŒãããã
ããŒãããã³ãŸãšãŒãããµãªãã¬ãŒããïŒïŒïŒâ
ãžã¯ãããã³ãŸãšãŒããããªã¡ããã·ãã³ãŸãšãŒ
ãããžã¢ãããã³ãŒã³ã¹ã«ãããŒããã¯ãã¢ã°ãª
ã±ãŒãããã³ãŒã³ã¹ã«ãããŒãããžãããã«ã¢ã»
ããŒãåã³ïŒâã°ã«ã³ãŒã¹ãã¹ããšãŒããäŸç€ºã
ãåŸãã 以äžã®èª¬æã«æŒããŠãR5ãæ°ŽçŽ ååãè¡šãã
åŒïŒïŒã®æ¬çºæååç©ãäºçœ®æååç©ãšåŒç§°
ããR5ããæ°ŽçŽ ä»¥å€ã®åèšæå³ãæããåŒïŒïŒ
ã®æ¬çºæååç©ãäžçœ®æååç©ãšåŒç§°ããã 奜ãŸããæ¬çºæååç©ã¯ãäžèšåŒïŒïŒãæã
ïŒäœã眮æããåŸãïŒïŒïŒâãžã¢ã«ã³ãã·ãã³ãŒ
ã³ã¹ã«ãã³ã¢ããé¡ã§ããã ãåŒäžã ïœã¯ïŒããïŒã®ããããã®å€ã§ãããç¹ã«ïŒå
ã¯ïŒã§ããã R3åã³R4ã¯ããããïŒä¹è³ïŒåã®ççŽ ååã
æããäœçŽã¢ã«ãã«åºãè¡šããã R1åã³R2ã¯ããããæ°ŽçŽ ååãïŒä¹è³ïŒåã®
ççŽ ååãæããçŽéåã¯åæéã¢ã«ãã«åºãè¡š
ããããæãã¯çªçŽ ååãšçµåããŠïŒåã¯ïŒåã®
çµåãæããçªçŽ å«æè€çŽ ç°åŒåºãç¹ã«ïŒä¹è³ïŒ
åã®ççŽ ååãæããçŽéåã¯åæéã¢ã«ãã«åº
ã«ãã眮æåã¯æªçœ®æã®ãããªãžãåºãã¢ã«ããª
ãåºãããã©ãžãã«åºããããŒã«åºåã¯ãããªãž
ãåºã圢æãã R5ã¯æ°ŽçŽ ååãããã²ã³ãNO2ãNH2ãCF3ã
ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ã³ãã·åºåã¯
ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ãã«ã¹ã«ãã
ã«åºãè¡šãããã 奜ãŸããæ¬çºæååç©ã¯ãäžèšäžè¬åŒïŒïŒã
æãïŒäœã眮æããåŸãïŒïŒïŒâãžã¡ããã·ãã³
ãŒã³ã¹ã«ãã³ã¢ããé¡ã§ããã ãåŒäžãïœãR1ãR2ãR5ã¯åèšãšå矩ã§ããã æå©ãªæ¬çºæååç©ã¯ãïœãR1ãR2ãåè¿°ã®
æå³ãæããR5ãæ°ŽçŽ ãè¡šããåŒïŒïŒã®ïŒã
ïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³ã¢ããé¡ã§ã
ãããããã®ååç©ã¯äºçœ®æååç©ã§ããã åèšäºçœ®æååç©ã®äžã§ãæå©ãªæ¬çºæååç©
ã¯åŒïŒïŒãåŒäžã ïœãïŒåã¯ïŒã§ããã R5ãæ°ŽçŽ ååãè¡šããã
ãã䞊ã³ã«ãã®å¡©ã«ä¿ããæ¬çºæã¯ãŸããããå
åç©ã®è£œæ³ã«ä¿ããæ¬çºæã¯æåŸã«ãããæ°èŠãª
â眮æãã³ãŒã³ã¹ã«ãã³ã¢ãã䞊ã³ã«è¬å€äžèš±
容ãããææ©åã¯ç¡æ©é žã«ãã€ãŠåŸãããåèšå
åç©ã®å¡©ãæå¹æåãšããŠå«æããæ°ããå»è¬ã«
ä¿ããæ¬çºæã«ããæ°ããâ眮æãã³ãŒã³ã¹ã«
ãã³ã¢ããã¯äžèšäžè¬åŒãæããã ãåŒäžã ïœåã³ïœã¯ããããïŒããïŒã®ããããã®å€ã§
ããã R3åã³R4ã¯ããããïŒä¹è³ïŒåã®ççŽ ååã
æããäœçŽã¢ã«ãã«åºãè¡šããã R1åã³R2ã¯ããããæ°ŽçŽ ååãïŒä¹è³ïŒåã®
ççŽ ååãæããçŽéåã¯åå²éã¢ã«ãã«åºãè¡š
ããããæãã¯çªçŽ ååãšçµåããŠïŒåã¯ïŒåã®
çµåïŒ1inkïŒãæããè€çŽ ç°åŒçªçŽ å«æåºãç¹ã«
ççŽ æ°ïŒä¹è³ïŒã®çŽéåã¯åå²éã¢ã«ãã«åºã«ã
ã眮æåã¯æªçœ®æã®ãããªãžãåºãã¢ã«ããªã
åºãããã©ãžãã«åºããããŒã«åºåã¯ãããªãžã
åºã圢æããŠããã R5ã¯æ°ŽçŽ ååãããã²ã³ãNO2ãNH2ãCF3ã
ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ã³ãã·åºåã¯
ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ãã«ã¹ã«ãã
ã«åºãè¡šããã R6åã³R7ã¯ããããæ°ŽçŽ ååãïŒä¹è³ïŒåã®
ççŽ ååãæããã¢ã«ãã«åºåã¯ïŒä¹è³ïŒåã®ç
çŽ ååãæããã·ã¯ãã¢ã«ãã«åºãè¡šããã æ¬çºæã¯ãè¬å€äžïŒphysiologicallyïŒèš±å®¹ã
ããææ©åã¯ç¡æ©é žãçšããŠåŸãããåŒïŒïŒã®
ååç©ã®ä»å å¡©ã«ãä¿ãã æ¬çºæã¯R7ãæ°ŽçŽ ååã§ãªãåŒïŒïŒã®åå
ç©äžŠã³ã«è¬å€äžèš±å®¹ãããææ©åã¯ç¡æ©é žãçšã
ãŠåŸãããåèšååç©ã®å¡©ã®å åŠç°æ§äœãã¹ãŠã«
é¢ããã è¬å€äžèš±å®¹ãããææ©åã¯ç¡æ©å¡©ãšããŠã¯ãã
ã€ããã¯ããªãããã€ãããããããç¡«é žå¡©ãç
é žå¡©ãã¡ã¿ã³ã¹ã«ãããŒããã¢ã»ããŒããããã¬
ãŒããã¹ã¯ã·ããŒããã©ã¯ããŒãããã«ããŒãã
ã·ãã¬ãŒãããã¿ãŒãã¬ãŒãããã¬ãšãŒãããã
ããŒãããã³ãŸãšãŒãããµãªãã¬ãŒããïŒïŒïŒâ
ãžã¯ãããã³ãŸãšãŒããããªã¡ããã·ãã³ãŸãšãŒ
ãããžã¢ãããã³ãŒã³ã¹ã«ãããŒããã¯ãã¢ã°ãª
ã±ãŒãããã³ãŒã³ã¹ã«ãããŒãããžãããã«ã¢ã»
ããŒãåã³ïŒâã°ã«ã³ãŒã¹ãã¹ããšãŒããäŸç€ºã
ãåŸãã 以äžã®èª¬æã«æŒããŠãR5ãæ°ŽçŽ ååãè¡šãã
åŒïŒïŒã®æ¬çºæååç©ãäºçœ®æååç©ãšåŒç§°
ããR5ããæ°ŽçŽ ä»¥å€ã®åèšæå³ãæããåŒïŒïŒ
ã®æ¬çºæååç©ãäžçœ®æååç©ãšåŒç§°ããã 奜ãŸããæ¬çºæååç©ã¯ãäžèšåŒïŒïŒãæã
ïŒäœã眮æããåŸãïŒïŒïŒâãžã¢ã«ã³ãã·ãã³ãŒ
ã³ã¹ã«ãã³ã¢ããé¡ã§ããã ãåŒäžã ïœã¯ïŒããïŒã®ããããã®å€ã§ãããç¹ã«ïŒå
ã¯ïŒã§ããã R3åã³R4ã¯ããããïŒä¹è³ïŒåã®ççŽ ååã
æããäœçŽã¢ã«ãã«åºãè¡šããã R1åã³R2ã¯ããããæ°ŽçŽ ååãïŒä¹è³ïŒåã®
ççŽ ååãæããçŽéåã¯åæéã¢ã«ãã«åºãè¡š
ããããæãã¯çªçŽ ååãšçµåããŠïŒåã¯ïŒåã®
çµåãæããçªçŽ å«æè€çŽ ç°åŒåºãç¹ã«ïŒä¹è³ïŒ
åã®ççŽ ååãæããçŽéåã¯åæéã¢ã«ãã«åº
ã«ãã眮æåã¯æªçœ®æã®ãããªãžãåºãã¢ã«ããª
ãåºãããã©ãžãã«åºããããŒã«åºåã¯ãããªãž
ãåºã圢æãã R5ã¯æ°ŽçŽ ååãããã²ã³ãNO2ãNH2ãCF3ã
ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ã³ãã·åºåã¯
ïŒä¹è³ïŒåã®ççŽ ååãæããã¢ã«ãã«ã¹ã«ãã
ã«åºãè¡šãããã 奜ãŸããæ¬çºæååç©ã¯ãäžèšäžè¬åŒïŒïŒã
æãïŒäœã眮æããåŸãïŒïŒïŒâãžã¡ããã·ãã³
ãŒã³ã¹ã«ãã³ã¢ããé¡ã§ããã ãåŒäžãïœãR1ãR2ãR5ã¯åèšãšå矩ã§ããã æå©ãªæ¬çºæååç©ã¯ãïœãR1ãR2ãåè¿°ã®
æå³ãæããR5ãæ°ŽçŽ ãè¡šããåŒïŒïŒã®ïŒã
ïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³ã¢ããé¡ã§ã
ãããããã®ååç©ã¯äºçœ®æååç©ã§ããã åèšäºçœ®æååç©ã®äžã§ãæå©ãªæ¬çºæååç©
ã¯åŒïŒïŒãåŒäžã ïœãïŒåã¯ïŒã§ããã R5ãæ°ŽçŽ ååãè¡šããã
ãåŒãããžã¡ãã«ã¢ããããžãšãã«ã¢ããã
ãããªãžãããããªãžããã¢ã«ããªãåºåã¯ïŒäœ
ãã¡ãã«åºã§çœ®æãããŠãããããªãžãåºããæ
ãã°ã«ãŒãããéžæãããåºã®äžã€ãè¡šãããã
æããã æå©ãªæ¬çºæååç©ã¯ãåŒïŒïŒãåŒäžãïœã
R1åã³R2ã¯åè¿°ã®æå³ãæããR5ãæ°ŽçŽ ä»¥å€ã®
åè¿°ã®æå³ãæããããæãïŒäœã眮æããåŸã
ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³ã¢ããé¡ã§
ããããããã®ååç©ã¯äžçœ®æååç©ã§ããã ãããäžçœ®æååç©ã®äžã§ãæå©ãªæ¬çºæåå
ç©ã¯åŒïŒïŒãåŒäžãR5ã¯ClãBrãOCH3ã
SO2C2H5ãSO2nC3H7ãSO2iC3H7ãè¡šãããã®
ååç©é¡ã§ããã å¥ã®æå©ãªæ¬çºæã«ããäžçœ®æååç©ã¯ãåŒ
ïŒïŒãåŒäžãR5ã¯ClïŒBrïŒOCH3ãè¡šãããã
æããã æ¬çºæã«ããå¥ã®å¥œãŸããäžçœ®æååç©ã¯ãåŒ
ïŒïŒãåŒäžã ïœã¯ïŒåã¯ïŒã§ããã R5ã¯OCH3ãClãBrãSO2âCH3ãSO2C2H5ã
SO2nC3H7ãSO2iC3H7ãè¡šããã
ãã¡ãã«åºã§çœ®æãããŠãããããªãžãåºããæ
ãã°ã«ãŒãããéžæãããåºã®äžã€ãè¡šãããã
æããã æå©ãªæ¬çºæååç©ã¯ãåŒïŒïŒãåŒäžãïœã
R1åã³R2ã¯åè¿°ã®æå³ãæããR5ãæ°ŽçŽ ä»¥å€ã®
åè¿°ã®æå³ãæããããæãïŒäœã眮æããåŸã
ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³ã¢ããé¡ã§
ããããããã®ååç©ã¯äžçœ®æååç©ã§ããã ãããäžçœ®æååç©ã®äžã§ãæå©ãªæ¬çºæåå
ç©ã¯åŒïŒïŒãåŒäžãR5ã¯ClãBrãOCH3ã
SO2C2H5ãSO2nC3H7ãSO2iC3H7ãè¡šãããã®
ååç©é¡ã§ããã å¥ã®æå©ãªæ¬çºæã«ããäžçœ®æååç©ã¯ãåŒ
ïŒïŒãåŒäžãR5ã¯ClïŒBrïŒOCH3ãè¡šãããã
æããã æ¬çºæã«ããå¥ã®å¥œãŸããäžçœ®æååç©ã¯ãåŒ
ïŒïŒãåŒäžã ïœã¯ïŒåã¯ïŒã§ããã R5ã¯OCH3ãClãBrãSO2âCH3ãSO2C2H5ã
SO2nC3H7ãSO2iC3H7ãè¡šããã
ãåŒãã¯ãžã¡ãã«ã¢ããåºããžãšãã«ã¢ãã
åºããããªãžãåºããããªãžãåºãã¢ã«ããªãåº
åã¯ç¹ã«ïŒäœãã¡ãã«åºã§çœ®æãããŠãããããª
ãžãåºããæãã°ã«ãŒãããéžæãããåºã®äžã€
ãè¡šãããã®ååç©é¡ã§ããã æ¬çºæã«ãã奜ãŸããäžçœ®æååç©ã¯ãåŒ
ïŒïŒ ãåŒäžã ïœã¯ïŒåã¯ïŒã§ããã R5ã¯ClãBrãSO2CH3ãSO2C2H5ãè¡šããã
åã¯ç¹ã«ïŒäœãã¡ãã«åºã§çœ®æãããŠãããããª
ãžãåºããæãã°ã«ãŒãããéžæãããåºã®äžã€
ãè¡šãããã®ååç©é¡ã§ããã æ¬çºæã«ãã奜ãŸããäžçœ®æååç©ã¯ãåŒ
ïŒïŒ ãåŒäžã ïœã¯ïŒåã¯ïŒã§ããã R5ã¯ClãBrãSO2CH3ãSO2C2H5ãè¡šããã
ãåŒãã¯ãããªãžãåºããããªãžãåºåã¯ã¢
ã«ããªãåºãè¡šããããæããã
ç¹ã«æå©ãªäžçœ®æååç©ã¯ãåŒïŒïŒãåŒäžã
ïœã¯ïŒåã¯ïŒã§ããã
R5ã¯ClãBrãSO2CH3ãè¡šããã
ãåŒãã¯ãããªãžãåºããããªãžãåºåã¯ã¢
ã«ããªãåºãè¡šããããæããã
å¥ã®æå©ãªæ¬çºæäžçœ®æååç©ã¯ãåŒïŒïŒ
ãåŒäžã ïœã¯ïŒã§ããã R5ã¯ClãBrãSO2CH3ãOCH3ãè¡šããã
ãåŒäžã ïœã¯ïŒã§ããã R5ã¯ClãBrãSO2CH3ãOCH3ãè¡šããã
ãåŒãã¯ã¢ã«ããªãåºãè¡šããããæããã
æ¬çºæã«ããå¥ã®æå©ãªäžçœ®æååç©ã¯ãåŒ
ïŒïŒãåŒäžã ïœã¯ïŒã§ããã R5ã¯SO2C2H5ãè¡šããã
ïŒïŒãåŒäžã ïœã¯ïŒã§ããã R5ã¯SO2C2H5ãè¡šããã
ãåŒãã¯ãžãšãã«ã¢ããåºãè¡šããããæã
ãååç©ãåã¯åŒïŒïŒãåŒäžã
ïœã¯ïŒã§ããã
R5ã¯SO2C2H5ãè¡šããã
ãåŒãã¯ãžã¡ãã«ã¢ããåã¯ãžãšãã«ã¢ãã
åºãè¡šããããæããååç©ã§ããã
ãããçš®ã
ã®å¥œãŸããååç©ã¯å¡©ç¹ã«ãã€ãã
ã¯ããªãã®åœ¢ç¶ã§ããã®ã奜ãŸããã æ¬çºæååç©ã補é ããããã«ãã¹ã«ããã©ã€
ããç¹ã«äžèšåŒïŒïŒã®ã¹ã«ããã©ã€ãã䜿çšã
ãã ãåŒäžãã¯ããã²ã³ãç¹ã«èçŽ ã奜ãŸããã¯å¡©
çŽ ã§ãããR3åã³R4ã¯ããããïŒä¹è³ïŒåã®ç
çŽ ååãæããäœçŽã¢ã«ãã«åºãè¡šãããã¯
NH2ãé€ã以å€ã¯R5ãšå矩ã§ããïŒæèšããã°ã
æ°ŽçŽ ãããã²ã³ãïŒä¹è³ïŒåã®ççŽ ååãæãã
ã¢ã«ã³ãã·åºãïŒä¹è³ïŒåã®ççŽ ååãæããã¢
ã«ãã«ã¹ã«ããã«åºãNO2åºåã¯CF3åºãè¡šã
ãïŒã äžèšåŒïŒïŒã®ã¹ã«ããã©ã€ãã補é ãããã
ã«ãç¹ã«åŒïŒïŒ ãåŒäžããR3åã³R4ã¯åèšãšå矩ã§ãããã®
ã¹ã«ãã¯ããªãã補é ããããã«ãåŒïŒïŒ ãåŒäžããR3åã³R4ã¯åèšãšå矩ã§ãããã®
ã¢ãªãŒã«ã¢ãã³ã䜿çšããäžèšã¹ããããå®æœã
ãã ïœïŒ ãžã¢ãŸããŠã å¡©ãç¹ã«åŒïŒïŒã®ãžã¢ãŸã
ãŠã ã¯ããªãã圢æããããã®ãžã¢ãŸããŠã å¡©
ã¯å¯Ÿå¿ããããé žãç¹ã«å¡©é žã®æº¶æ¶²äžã§ã¢ãªãŒ
ã«ã¢ãã³ãäºç¡é žã¢ã«ã«ãªéå±ã®æº¶æ¶²ãšåå¿ã
ãã次ãã§åå¿æ··åç©ã奜ãŸããã¯çŽ10â以äž
ã®æž©åºŠã«ä¿ã€ããšã«ããåŸãããã ïœïŒ åŸããããžã¢ãŸããŠã å¡©ã溶液äžã§ç¡æ°Žäº
ç¡«é žãšåå¿ããããæäœã¯é ¢é žã®ååšã䞊ã³ã«
ãžã¢ãŸããŠã åºã®ã¹ã«ããã©ã€ããç¹ã«ã¹ã«ã
ã¯ããªããžã®è»¢åãä¿é²ããã®ã«é©ãã觊åªã®
ååšäžã§è¡ãããã®ã奜ãŸããããã®è§Šåªã¯ã
äŸãã°é ããŒã¹è§Šåªã§ããïŒä¿®æ£ãµã³ããã€ã€
ãŒåå¿ïŒã åŒïŒïŒã®ã¹ã«ãã¯ããªãã®è£œé ã«äŸãšããŠé©
çšããããã®åå¿ã®ã¹ãããïœïŒåã³ïœïŒã¯äžèš
åå¿åŒã§è¡šãããåŸãã åŒïŒïŒã®ã¹ã«ãã¯ããªãã®è£œé çšã¢ãªãŒã«ã¢
ãã³ãšããŠã¯ã次ã®ãã®ã奜ãŸããã ïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒâã¯ããâïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒâããã¢âïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒïŒïŒïŒïŒâããªã¡ããã·ã¢ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâã¡ãã«ã¹ã«ããã«ã¢
ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâãšãã«ã¹ã«ããã«ã¢
ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâãããã«ã¹ã«ããã«
ã¢ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâã€ãœãããã«ã¹ã«ã
ãã«ã¢ããªã³ã åŒïŒïŒãåŒäžãã¯åèšãšå矩ã§ãããã®ã¹
ã«ãã¯ããªãã補é ããããã«ã¯ãåŒïŒïŒ ãåŒäžããR3åã³R4ã¯åèšãšå矩ã§ãããã®
ååç©ãã¹ã«ãã³ååã¯ããã²ãã¹ã«ãã³åã奜
ãŸããã¯ã¯ããã¹ã«ãã³åããã ã¹ã«ãã³åïŒååç©ïŒïŒãšç¡«é žãšã®åå¿ã«ã
ãïŒã®å Žåã第äžæ®µéã«ãããŠåŒïŒïŒ ã®ã¹ã«ãã³é žãåŸãããã åŸãããé žïŒïŒã次ã«æ°Žé žåãããªãŠã ãæ°Ž
é žåã«ãªãŠã åã¯ããªãžã³ã®åŠãé©åœãªå¡©åºã«ã
ãææ©åã¯ç¡æ©å¡©åºã®å¡©ã«å€æããã ãã®å¡©ã¯äžèšåŒïŒïŒã«ããè¡šããããã ãåŒäžãB+ã¯éå±ãç¹ã«ã¢ã«ã«ãªåã¯ã¢ã«ã«ãª
åé¡éå±ãè¡šãããã¯åèšãšå矩ã§ããããåŒ
ïŒïŒã®å¡©åç©ã¯ãå¡©åããªãã«ãäºå¡©åçãå
ã¯ãªãã·å¡©åçã®åŠãå¡©çŽ åå€ããåŒïŒïŒã®å
åç©åã¯åŒïŒïŒã®ååç©ã®ææ©åã¯ç¡æ©å¡©ãžäœ
çšãããŠåŸãããã åŒïŒïŒã®ååç©ããåŒïŒïŒãåŒäžãã¯å
èšãšå矩ã§ãããã®ååç©ã補é ããããã®åå¿
ãã€ã¢ã°ã©ã ã®ïŒäŸã以äžã«ç€ºãã ã¯ããã¹ã«ãã³åã®å Žåãã¯ããã¹ã«ãã³é žã
åŒïŒïŒãåŒäžãïŒR3åã³R4ã¯åè¿°ã®æå³ãæ
ãããã®ååç©ãšäžèšã®åŠãåå¿ãããã åŒïŒïŒã®ååç©ã®ãã€ããã¯ããªãã¯ãåŒ
ïŒXIïŒ ãåŒäžã ïœåã³ïœã¯ããããïŒããïŒã®ããããã§ã
ããR1ãR2ãR6åã³R7ã¯åè¿°ã®æå³ãæããã
ã®ã¢ãã³ãšãåŒïŒïŒ ãåŒäžã R3åã³R4ã¯åè¿°ã®æå³ãæãã ã¯R5ãšå矩ã§ããããäœãNH2åºãé€ã
ïŒããå¥ã®ã¹ã«ããã©ã€ãäŸãã°ã¹ã«ããããã
ããåèšã¹ã«ãã¯ããªãã®ä»£ãã«äœ¿çšããããªã
ã°ãåŒïŒïŒã®ååç©ã®å¥ã®ããã²ããŒããåŸã
ããïŒãã®ã¹ã«ãã¯ããªããšã®åå¿ã«ããåŸãã
ãšãã§ããã åŒïŒïŒãåŒäžãR5ã¯NH2ãè¡šãããã®ååç©
ã¯ãæ¥è§Šæ°ŽçŽ æ·»å åã¯ååŠéå ã«ããåŒïŒïŒ
ãåŒäžãR5ã¯NO2ãè¡šãããã®ååç©ãéå ããŠ
補é ãããã 以äžã«è¿°ã¹ãŠããåŠãåŸãããåŒïŒïŒã®åå
ç©ã®ãã€ããã¯ããªãã¯åŒ ãæããã åèšåŒïŒXIIïŒã®ãã€ããã¯ããªãã溶液äžã§æ°Ž
é žåãããªãŠã ãåã¯æ°Žé žåã«ãªãŠã ãåã¯åç
ã®å¡©åºæ§ãæããä»ã®ä»»æã®å¡©åºã®åŠã匷塩åºãš
åå¿ããããšãå¡©ã®åœ¢ç¶ã§ãªããå³ã¡å¡©åºã®åœ¢ç¶
ã®åŒïŒïŒã®ååç©ãžå€åããã åŒïŒXIIïŒã®ãã€ããã¯ããªãã¯åŒïŒïŒã®å¡©åº
ã«è»¢ååŸåŸæ¥æ¹æ³ã§ãã®å¡©åºãå¡©åããããšã«ã
ã€ãŠçš®ã ã®å¡©ã«å€æããåŸãã åŒïŒïŒã®ååç©åã¯ãã®å¡©ã®è£œé ã«çšããã
ã奜ãŸããã¢ãã³ããäžèšã«ç€ºãã ãžã¡ãã«ã¢ããâãšãã«ã¢ãã³ã ãžãšãã«ã¢ããâãšãã«ã¢ãã³ã ãããªãžãâãšãã«ã¢ãã³ã ãããªãžãâãšãã«ã¢ãã³ã ã¢ã«ããªãâãšãã«ã¢ãã³ã ãžã¡ãã«ã¢ããâãããã«ã¢ãã³ã ãžãšãã«ã¢ããâãããã«ã¢ãã³ã ãããªãžãâãããã«ã¢ãã³ã ïŒâïŒïŒâã¡ãã«ãããªãžãïŒâãããã«ã¢ã
ã³ã ã¢ã«ããªãâãããã«ã¢ãã³ã ããã€ãã®ã¹ã«ãã¯ããªãåã³æ°èŠãªãã³ãŒã³
ã¹ã«ãã³ã¢ããã®è£œé ã«é¢ããäžèšã®ééå®çå®
æœäŸã«ãããæ¬çºæã説æããã å®æœäŸ ïŒ ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ããã«ã¯ããª
ãã®è£œé ããã¯C.M.SUTERåã³H.L.HANSENãJ.of
Am.Chem.Soc.1933ã55ã2080ã«å ±åããæ¹æ³ã«
åŸã€ãŠãïŒæ®µéã§è¡ãããã 第ïŒæ®µéïŒïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³
é žã«ãªãŠã ã®è£œé ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³85ïœïŒ0.615ã¢ã«ïŒ
ãã枩床èšã滎äžæŒæåã³ç£æ°æ¹æã·ã¹ãã ãå
ããäžéŠãã©ã¹ã³ïŒ250cm3ïŒã®äžã«å°å ¥ãããçŽ
ïŒâã«å·åŽåŸãç¡«é žïŒïœïŒ1.83â1.84ïŒ50cm3ïŒ0.9
ã¢ã«ïŒãäžæ»Žãã€å ããã次ã«æ··åç©ã宀枩ã«ã
ãŠ1.5æéæŸçœ®ãããåºåããåå¿æ··åç©ãçé ž
ã«ãªãŠã ã®é£œå溶液ïŒ138ïœïŒïŒ750cm3äžã«æ³šå ¥
åŸãäžæ©æŸçœ®ãããåŸãããæ²æ®¿ç©ãéåŸãªã³
æžå§ïŒCphosphoric vocuumïŒäžã§ä¹Ÿç¥ãããã åç 79ïŒ ç¬¬ïŒæ®µéïŒïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã
ã«ã¯ããªããžã®è»¢å ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³é žã«ãªãŠ
ã 124ïœïŒ0.484ã¢ã«ïŒãšããžã¡ãã«ãã«ã ã¢ãã
500cm3ãšããæ¹æã·ã¹ãã ãšå¡©åã«ã«ã·ãŠã ãã©
ãããšãåããäžéŠãã©ã¹ã³ïŒïŒãªããã«ïŒäžã«
é 次å°å ¥ãããåŸãããæžæ¿æ¶²ã«å¡©åããªãã«
69.5ïœïŒ0.583ã¢ã«ïŒã宀枩ã§ïŒæ»Žãã€å ããã
äžæ©æŸçœ®åŸãæ··åç©ãç ããæ°·ã«æ³šå ¥ãããåŸã
ããçœè²æ²æ®¿ç©ãè±æ°ŽåŸæ°Žã§ååæŽæµããŠãããª
ã³æžå§äžã§ä¹Ÿç¥ããã åç 75ïŒ ãmp72âïŒlitt.70.5âïŒ å®æœäŸ ïŒ ïŒïŒïŒïŒïŒâããªã¡ããã·ãã³ãŒã³ã¹ã«ããã«
ã¯ããªãã®è£œé ãã®è£œé ã¯ïŒã€ã®å·¥çšã«ãã€ãŠè¡ãããšãã§ã
ãã 第ïŒå·¥çš 枩床èšã滎äžæãå¡©åã«ã«ã·ãŠã ãã©ããå
ã³ç£æ°æ¹æã·ã¹ãã ãåãã500cm3äžã€å£ãã©ã¹
ã³ã«ã42ïœïŒ0.25ã¢ã«ïŒã®ïŒïŒïŒïŒïŒâããªã¡ã
ãã·ãã³ãŒã³ã®çŽç²ãªã¯ãããã«ã 200cm3溶液ã
å ¥ãããçªçŽ é°å²æ°äžã§â10âãŸã§å·åŽãããå
å¿åªè³ªã«ãã¯ããã¹ã«ãã³é ž80cm3ã滎äžæ·»å ã
ããã¯ãªãŒã ããã€ãçœè²ã®ãã«ã¯ç¶æ²æ®¿ãé 次
圢æããã次ãã§ç·è²ã®æº¶æ¶²ã¯è€è²ã«å€åããã
æ·»å ãå®äºããæã«ããã®åå¿åªè³ªã宀枩ã«ïŒæ
éæŸçœ®ãã次ã«ç Žç ããæ°·äžã«æ³šãã ãåŸããã
æ²æ®¿ãã¯ãããã«ã ã§æœåºãã次ã«ææ©çžãç¡«é ž
ãããªãŠã ã§ä¹Ÿç¥ãã次ãã§æžå§äžã§èžçºãã
ããç°è€è²ã®åºäœãçæãããŸã§ã圢æãããè€
è²æ®çç©ãæå°éã®ãã«ãšã³ã§æŽæ»ããã次ã«ã
ã®åºäœãã·ãªã«ã«ã©ã ã§ã¯ãããã°ã©ãåŠçã
ãã ãã³ãŒã³ã§æº¶åºããã次ã«ãã³ãŒã³âã¯ããã
ã«ã ïŒ50â50ïŒæ··åç©ã§æº¶åºããŠïŒïŒïŒïŒïŒâã
ãªã¡ããã·ãã³ãŒã³ã¹ã«ããã«ã¯ããªããåŸãã åç 46ïŒ ãmp147â NMRïŒCDCl3ïŒã80MHzïŒ ÎŽ7.29ppmïŒïœã1HãArHïŒïŒÎŽ6.55ppmïŒïœã
1HãArHïŒïŒÎŽ3.93ã3.78åã³3.53ppmïŒ3aã
9HãOCH3ïŒãIRïŒKBrïŒïŒÎœSO2ã1350cm-1
ïŒasïŒã1160cm-1ïŒïœïŒã 第ïŒå·¥çš ãã®å·¥çšã¯ïŒã€ã®ã¹ããããããªãã ïŒïŒïŒâãžã¡ããã·ã¯ãããã³ãŒã³ïŒ ç£æ°æ¹æã·ã¹ãã ã枩床èšãå¡©åã«ã«ã·ãŠã ã
ã©ããåã³æ»ŽäžæãåããïŒäžã€å£ãã©ã¹ã³
ã«ãïŒâã«å·åŽãããã©ãããŒã«138ïœïŒïŒã¢ã«ïŒ
ãç¶ç¶ããŠå°å ¥ãã次ã«ã¹ã«ããªã«ã¯ããªã135
ïœïŒïŒã¢ã«ïŒã滎äžãããæ·»å ãçµäºãããšã
ã«ãåå¿åªè³ªã宀枩ã«ãã次ãã§ïŒæéé眮åŸã
æžå§äžã§èžçããã åç 83ïŒ ãb.p.120âã1999.83ãã¹ã«ã«ïŒ15
mmHgïŒã ïŒïŒïŒâãžã¡ããã·âïŒâãããã¯ãããã³ãŒ
ã³ïŒ ç£æ°æ¹æã·ã¹ãã ã枩床èšãåã³æ»Žäžæãå
ããïŒäžã€å£ãã©ã¹ã³ã«ïŒïŒïŒâãžã¡ããã·ã¯
ãããã³ãŒã³143.9ïœïŒ0.83ã¢ã«ïŒãç¶ç¶ããŠå°
å ¥ãã次ã«æž©åºŠã25âãè¶ããªãããã«ããŠç¡é ž
ïŒïœïŒ1.38ïŒ166cm3ã滎äžãããæ·»å çµäºæã«ãå
å¿æ··åç©ã1.5æéé眮ãã次ãã§éããã åç 95ïŒ ãm.p.105â ïŒïŒïŒïŒïŒâããªã¡ããã·ããããã³ãŒã³ïŒ å·åŽè£ 眮ãåããïŒãã©ã¹ã³ã«ãæ°Žé žåã«ãª
ãŠã ã®ã¡ã¿ããŒã«æº¶æ¶²ïŒã¡ã¿ããŒã«500cm3äžã«
KOH100ïœïŒãç¶ç¶ããŠå°å ¥ãã次ã«ïŒïŒïŒâãž
ã¡ããã·âïŒâãããã¯ãããã³ãŒã³100ïœ
ïŒ0.46ã¢ã«ïŒãšã«ãŒãã©ã³ãã ãå°å ¥ããããã®
æ··åç©ãéæµäžã§ïŒæé沞隰ããããå·åŽåŸãå
å¿åªè³ªãéããåŸãããæ²æ®¿ãã¡ã¿ããŒã«ã§æŽ
æ»ããã åç 95ïŒ ãm.p.129â ïŒïŒïŒïŒïŒâããªã¡ããã·ã¢ããªã³ïŒ å·åŽè£ 眮ãåãã500cm3ãã©ã¹ã³ã«ãïŒïŒïŒïŒ
ïŒâããªã¡ããã·ããããã³ãŒã³21.3ïœïŒ0.1ã¢
ã«ïŒãéå±é¡çæçšã®ååŠçã«çŽç²ãªå¡©å第ïŒé«
80ïœãå¡©é žæº¶æ¶²ïŒïœïŒ1.18ïŒ100cm3åã³ã«ãŒãã©
ã³ãã ãé 次添å ããããã®æ··åç©ãïŒæééæµ
äžã§æ²žéš°ããããå·åŽåŸãæ²æ®¿ã溶解ãããŸã§è
æ§ãœãŒã溶液ãæ·»å ãããåŸããã溶液ãå¡©åã¡
ãã¬ã³ã§æœåºãããææ©æœåºç©ãç¡«é žãããªãŠã
ã§ä¹Ÿç¥ãã次ã«æžå§äžã§èžçºããããåŸãããæ®
çç©ããšã¿ããŒã«äžã§æ¶åºãããã åç 80ïŒ ïŒm.p.94â ïŒïŒïŒïŒïŒâããªã¡ããã·ãã³ãŒã³ã¹ã«ããã«
ã¯ããªãïŒ æ¹æã·ã¹ãã åã³æž©åºŠèšãåãã250cm3ã®äžã€
å£ãã©ã¹ã³ã«ãïŒïŒïŒïŒïŒâããªã¡ããã·ã¢ããª
ã³18.3ïœïŒ0.1ã¢ã«ïŒãå°å ¥ãã次ãã§å¡©é žæº¶æ¶²
ïŒïœïŒ1.18ïŒ50cm3ãå°å ¥ãããïŒæéæŸçœ®åŸãäº
ç¡é žãããªãŠã 溶液ïŒæ°Ž50cm3ã«NaNO210ïœïŒã
æ·»å ããŠãã®ã¢ãã³ãâïŒâã§ãžã¢ãŸåãããåŸ
ããããžã¢ãŸããŠã å¡©ãã40âã«å ç±ããçªçŽ é°
å²æ°äžã«ãããäºé žåç¡«é»ã§é£œåããé ¢é ž200cm3
ãšå¡©å第äºé ïŒïœãšãå«æããäžã€å£ãã©ã¹ã³ã«
åŸã ã«æ³šãã ãæ··åç©ãïŒæé60âã«ä¿æãã次
ãã§ç Žç ããæ°·äžã«æ³šãã ã åç 35ïŒ ïŒm.p.147â å®æœäŸ ïŒ ïŒâã¯ããâïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«
ããã«ã¯ããªãã®è£œé ãã®è£œé ã¯ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ããïŒ
ã€ã®ã¹ãããã§è¡ãããã 第ïŒã¹ãããïŒïŒïŒïŒâãžã¡ããã·ã¯ãããã³ãŒ
ã³ã®è£œé ãã®è£œé ã¯Annali di Chimicaã43å·»ã293é
ïŒ1953幎ïŒã«G.Castelfranchiåã³G.Borraãå ±å
ããæ¹æ³ã«åŸã€ãŠè¡ãããã ç£æ°æ¹æã·ã¹ãã ã枩床èšãå¡©åã«ã«ã·ãŠã ã
ã©ããåã³æ»Žäžæãåãã10âã«å·åŽãã500
cm3äžã€å£ãã©ã¹ã³ã«ãïŒïŒïŒâãžã¡ããã·ãã³ãŒ
ã³97.5ïœïŒ0.70ã¢ã«ïŒãç¶ç¶ããŠå°å ¥ãã次ãã§
ã¹ã«ããªã«ã¯ãã©ã€ã96.5ïœïŒ0.70ã¢ã«ïŒã滎äž
ãããæ·»å çµäºãšåæã«ã溶液ã宀枩ã«ãã©ã
ãŠãïŒæéæŸçœ®ã次ã«èžçããã åç 85ïŒ ãb.p.137âã2399.80ãã¹ã«ã«ïŒ18
mmHgïŒãã 第ïŒã¹ãããïŒïŒâã¯ããâïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ããã«ã¯ãã©ã€ããžã®è»¢
å ç£æ°æ¹æã·ã¹ãã ãå¡©åã«ã«ã·ãŠã ãã©ããã
枩床èšåã³æ»Žäžæãåãã500cm3äžã€å£ãã©ã¹
ã³ã«ã35ïœïŒ0.2ã¢ã«ïŒã®ïŒïŒïŒâãžã¡ããã·ã¯
ãããã³ãŒã³ã®250cm3ã®çŽç²ãªã¯ãããã«ã 溶液
ãå°å ¥ããã溶液ãïŒâã«å·åŽãã次ã«ã¯ããã¹
ã«ãã³é ž50cm3ïŒ0.75ã¢ã«ïŒã滎å è¿œå ãããæ·»å
çµäºãšåæã«ãåå¿åªè³ªã宀枩ã«æ»ãã次ã«ïŒæ
éæŸçœ®åŸãç Žç ããæ°·ã®äžã«æ³šãã ãåŸãããæ··
åç©ãã¯ãããã«ã ã§æœåºãããææ©æœåºç©ãç¡«
é žãããªãŠã ã§ä¹Ÿç¥ãã次ãã§æ¿çž®ããŠæ¶åºãã
ããåŸãããåºäœããšãã«ãšãŒãã«ïŒãã³ãŒã³æ··
åç©ããåçµæ¶ãããã åç 74ïŒ ãm.p.175â NMRïŒCDCl3ïŒã80MHzïŒ ÎŽ7.87ppmïŒïœã1HãArHïŒïŒÎŽ6.55ppmïŒïœã
1HãArHïŒïŒÎŽ4åã³3.96ppmïŒ2sã6Hã
OCH3ïŒ 1RïŒKBrïŒïŒÎœSO2ã1385cm-1ïŒasïŒã1170cm-1
ïŒïœïŒ å®æœäŸ ïŒ ïŒâããã¢âïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«
ããã«ã¯ããªãã®è£œé ãã®è£œé ã¯ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ããïŒ
ã€ã®ã¹ãããã§è¡ã€ãã 第ïŒã¹ãããïŒïŒïŒïŒâãžã¡ããã·ããã¢ãã³ãŒ
ã³ã®è£œé ãã®è£œé ã¯Hsu^eh Paoã25å·»ã277é ïŒ1959
幎ïŒã«S.T.Fengåã³K.Y.Chiuãå ±åããæ¹æ³ã«
åŸã€ãŠè¡ãããã ç£æ°æ¹æã·ã¹ãã åã³æž©åºŠèšãåãã10âã«å·
åŽãã250cm3ã®äžã€å£ãã©ã¹ã³ã«ãïŒïŒïŒâãžã¡
ããã·ãã³ãŒã³27.6ïœïŒ0.2ã¢ã«ïŒãç¶ç¶ããŠå
ãã次ã«ïŒ®âããã¢ã¹ã¯ã·ã³ã€ãã36ïœïŒ0.2ã¢
ã«ïŒãå°éã¥ã€æ·»å ãããæ·»å çµäºåŸçŽã¡ã«ãå
å¿åªè³ªã宀枩ã«æ»ããŠïŒæéæŸçœ®ãããæ°Žã§æŽæ»
ããŠã¯ãããã«ã ã§æœåºããåŸãææ©æœåºç©ãç¡«
é žãããªãŠã ã§ä¹Ÿç¥ãã次ãã§æžå§äžã§æ¿çž®ã
ããæ®ç液äœãèžçããã åç 82ïŒ ãb.p.150âã1999.83ãã¹ã«ã«ïŒ15
mmHgïŒã 第ïŒã¹ãããïŒïŒâããã¢âïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ããã«ã¯ããªããžã®è»¢å ïŒâã¯ããâïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«
ããã«ã¯ããªãã補é ããå®æœäŸïŒã«èšèŒãããš
åãæ¹æ³ã§è£œé ããããïŒïŒïŒâãžã¡ããã·ãã
ã¢ãã³ãŒã³65.1ïœãžïŒ0.3ã¢ã«ïŒãšã¯ããã¹ã«ã
ã³é ž100cm3ãçšãããåçã¯77ïŒ ã§ãã€ãã m.p.195â NMRïŒCDCl3ïŒã60MHz ÎŽ7.85ppmïŒïœã1HãArHïŒïŒ6.70ppmïŒïœã1Hã
ArHïŒïŒÎŽ3.92åã³3.88ppmïŒ2sã6Hã
OCH3ïŒïŒ IRïŒKBrïŒïŒÎœSO2ã1385cm-1ïŒasïŒã1165cm-1
ïŒïœïŒ å®æœäŸ ïŒ ïŒâã¢ã«ãã«ã¹ã«ããã«âïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ããã«ã¯ããªã ãããå¡©åç©ã¯ãå®æœäŸïŒã«èšèŒã®ïŒïŒïŒâãž
ã¡ããã·ãã³ãŒã³ã¹ã«ããã«ã¯ããªãããåŸãã
ãããããã補é ããããã®äžè¬çãªåå¿ãã€ã¢
ã°ã©ã ã¯äžèšã®éãã§ããã ïŒïŒïŒâãžã¡ããã·ãã³ãŒã«ã¹ã«ãã€ã³é ž ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ããã«ã¯ããª
ã115ïœïŒ0.487ã¢ã«ïŒãå°éãã€æ¹æããªããã
äºç¡«é žãããªãŠã 129ïœïŒ0.974ã¢ã«ïŒãå«ã氎溶
液ã«æ·»å ããããã®æäœäžã«ãèæ§ãœãŒããæ·»å
ããããšã«ãã€ãŠPHãã¢ã«ã«ãªæ§ã«ä¿æãããïŒ
æéé眮ããåŸãåå¿æ··åç©ãéãããã¹ã«ã
ã€ã³é žãæ²æ®¿ãããŸã§ã液ã2Nç¡«é žã§é žæ§å
ããã åç 72ïŒ ãm.p.122â ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã€ã³é žãã
ãªãŠã ïŒ ååŠéè«éã®æ°Žé žåãããªãŠã ãå«æãã氎溶
液ãæ·»å ããããšã«ãã€ãŠãïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ãã€ã³é žãããªãŠã ãåŸãããã®ã¹
ã«ãã€ã³é žå¡©æº¶æ¶²ãèžçºä¹Ÿæ¶žããã ïŒïŒïŒïŒâãžã¡ããã·ããšãã«ïŒã¢ã«ãã«ã¹ã«
ãã³ äžè¬çæ¹æ³ïŒ å·åŽã·ã¹ãã ãšç£æ°æ¹æã·ã¹ãã ãåãã500
cm3ãã©ã¹ã³ã«ãïŒïŒïŒâãžã¡ããã·âãã³ãŒã³ã
ã«ãã³é žãããªãŠã 0.1ã¢ã«ãã€ãœãããããŒã«
250cm3åã³ããã²ã³åã¢ã«ãã«ã奜ãŸããã¯æ²å
ã¢ã«ãã«0.15ã¢ã«ãé 次添å ãããçšããããã
ãã²ã³åç©ã«å¿ããŠãã®æ··åç©ãïŒã30æééæµ
äžã§æ²žéš°ããããå·åŽåŸãåå¿åªè³ªãèžçºä¹Ÿåºã
ããæ®çç©ãæ°Žäžã«åãåºãã次ã«ã¯ãããã«ã
ã§æœåºãããç¡«é žãããªãŠã ã§ä¹Ÿç¥ããåŸãææ©
çžãèžçºãããŠãªã€ã«ãåŸãããã®ãªã€ã«ããã³
ãŒã³äžã§æ¶åºãããã
ã¯ããªãã®åœ¢ç¶ã§ããã®ã奜ãŸããã æ¬çºæååç©ã補é ããããã«ãã¹ã«ããã©ã€
ããç¹ã«äžèšåŒïŒïŒã®ã¹ã«ããã©ã€ãã䜿çšã
ãã ãåŒäžãã¯ããã²ã³ãç¹ã«èçŽ ã奜ãŸããã¯å¡©
çŽ ã§ãããR3åã³R4ã¯ããããïŒä¹è³ïŒåã®ç
çŽ ååãæããäœçŽã¢ã«ãã«åºãè¡šãããã¯
NH2ãé€ã以å€ã¯R5ãšå矩ã§ããïŒæèšããã°ã
æ°ŽçŽ ãããã²ã³ãïŒä¹è³ïŒåã®ççŽ ååãæãã
ã¢ã«ã³ãã·åºãïŒä¹è³ïŒåã®ççŽ ååãæããã¢
ã«ãã«ã¹ã«ããã«åºãNO2åºåã¯CF3åºãè¡šã
ãïŒã äžèšåŒïŒïŒã®ã¹ã«ããã©ã€ãã補é ãããã
ã«ãç¹ã«åŒïŒïŒ ãåŒäžããR3åã³R4ã¯åèšãšå矩ã§ãããã®
ã¹ã«ãã¯ããªãã補é ããããã«ãåŒïŒïŒ ãåŒäžããR3åã³R4ã¯åèšãšå矩ã§ãããã®
ã¢ãªãŒã«ã¢ãã³ã䜿çšããäžèšã¹ããããå®æœã
ãã ïœïŒ ãžã¢ãŸããŠã å¡©ãç¹ã«åŒïŒïŒã®ãžã¢ãŸã
ãŠã ã¯ããªãã圢æããããã®ãžã¢ãŸããŠã å¡©
ã¯å¯Ÿå¿ããããé žãç¹ã«å¡©é žã®æº¶æ¶²äžã§ã¢ãªãŒ
ã«ã¢ãã³ãäºç¡é žã¢ã«ã«ãªéå±ã®æº¶æ¶²ãšåå¿ã
ãã次ãã§åå¿æ··åç©ã奜ãŸããã¯çŽ10â以äž
ã®æž©åºŠã«ä¿ã€ããšã«ããåŸãããã ïœïŒ åŸããããžã¢ãŸããŠã å¡©ã溶液äžã§ç¡æ°Žäº
ç¡«é žãšåå¿ããããæäœã¯é ¢é žã®ååšã䞊ã³ã«
ãžã¢ãŸããŠã åºã®ã¹ã«ããã©ã€ããç¹ã«ã¹ã«ã
ã¯ããªããžã®è»¢åãä¿é²ããã®ã«é©ãã觊åªã®
ååšäžã§è¡ãããã®ã奜ãŸããããã®è§Šåªã¯ã
äŸãã°é ããŒã¹è§Šåªã§ããïŒä¿®æ£ãµã³ããã€ã€
ãŒåå¿ïŒã åŒïŒïŒã®ã¹ã«ãã¯ããªãã®è£œé ã«äŸãšããŠé©
çšããããã®åå¿ã®ã¹ãããïœïŒåã³ïœïŒã¯äžèš
åå¿åŒã§è¡šãããåŸãã åŒïŒïŒã®ã¹ã«ãã¯ããªãã®è£œé çšã¢ãªãŒã«ã¢
ãã³ãšããŠã¯ã次ã®ãã®ã奜ãŸããã ïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒâã¯ããâïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒâããã¢âïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒïŒïŒïŒïŒâããªã¡ããã·ã¢ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâã¡ãã«ã¹ã«ããã«ã¢
ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâãšãã«ã¹ã«ããã«ã¢
ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâãããã«ã¹ã«ããã«
ã¢ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâã€ãœãããã«ã¹ã«ã
ãã«ã¢ããªã³ã åŒïŒïŒãåŒäžãã¯åèšãšå矩ã§ãããã®ã¹
ã«ãã¯ããªãã補é ããããã«ã¯ãåŒïŒïŒ ãåŒäžããR3åã³R4ã¯åèšãšå矩ã§ãããã®
ååç©ãã¹ã«ãã³ååã¯ããã²ãã¹ã«ãã³åã奜
ãŸããã¯ã¯ããã¹ã«ãã³åããã ã¹ã«ãã³åïŒååç©ïŒïŒãšç¡«é žãšã®åå¿ã«ã
ãïŒã®å Žåã第äžæ®µéã«ãããŠåŒïŒïŒ ã®ã¹ã«ãã³é žãåŸãããã åŸãããé žïŒïŒã次ã«æ°Žé žåãããªãŠã ãæ°Ž
é žåã«ãªãŠã åã¯ããªãžã³ã®åŠãé©åœãªå¡©åºã«ã
ãææ©åã¯ç¡æ©å¡©åºã®å¡©ã«å€æããã ãã®å¡©ã¯äžèšåŒïŒïŒã«ããè¡šããããã ãåŒäžãB+ã¯éå±ãç¹ã«ã¢ã«ã«ãªåã¯ã¢ã«ã«ãª
åé¡éå±ãè¡šãããã¯åèšãšå矩ã§ããããåŒ
ïŒïŒã®å¡©åç©ã¯ãå¡©åããªãã«ãäºå¡©åçãå
ã¯ãªãã·å¡©åçã®åŠãå¡©çŽ åå€ããåŒïŒïŒã®å
åç©åã¯åŒïŒïŒã®ååç©ã®ææ©åã¯ç¡æ©å¡©ãžäœ
çšãããŠåŸãããã åŒïŒïŒã®ååç©ããåŒïŒïŒãåŒäžãã¯å
èšãšå矩ã§ãããã®ååç©ã補é ããããã®åå¿
ãã€ã¢ã°ã©ã ã®ïŒäŸã以äžã«ç€ºãã ã¯ããã¹ã«ãã³åã®å Žåãã¯ããã¹ã«ãã³é žã
åŒïŒïŒãåŒäžãïŒR3åã³R4ã¯åè¿°ã®æå³ãæ
ãããã®ååç©ãšäžèšã®åŠãåå¿ãããã åŒïŒïŒã®ååç©ã®ãã€ããã¯ããªãã¯ãåŒ
ïŒXIïŒ ãåŒäžã ïœåã³ïœã¯ããããïŒããïŒã®ããããã§ã
ããR1ãR2ãR6åã³R7ã¯åè¿°ã®æå³ãæããã
ã®ã¢ãã³ãšãåŒïŒïŒ ãåŒäžã R3åã³R4ã¯åè¿°ã®æå³ãæãã ã¯R5ãšå矩ã§ããããäœãNH2åºãé€ã
ïŒããå¥ã®ã¹ã«ããã©ã€ãäŸãã°ã¹ã«ããããã
ããåèšã¹ã«ãã¯ããªãã®ä»£ãã«äœ¿çšããããªã
ã°ãåŒïŒïŒã®ååç©ã®å¥ã®ããã²ããŒããåŸã
ããïŒãã®ã¹ã«ãã¯ããªããšã®åå¿ã«ããåŸãã
ãšãã§ããã åŒïŒïŒãåŒäžãR5ã¯NH2ãè¡šãããã®ååç©
ã¯ãæ¥è§Šæ°ŽçŽ æ·»å åã¯ååŠéå ã«ããåŒïŒïŒ
ãåŒäžãR5ã¯NO2ãè¡šãããã®ååç©ãéå ããŠ
補é ãããã 以äžã«è¿°ã¹ãŠããåŠãåŸãããåŒïŒïŒã®åå
ç©ã®ãã€ããã¯ããªãã¯åŒ ãæããã åèšåŒïŒXIIïŒã®ãã€ããã¯ããªãã溶液äžã§æ°Ž
é žåãããªãŠã ãåã¯æ°Žé žåã«ãªãŠã ãåã¯åç
ã®å¡©åºæ§ãæããä»ã®ä»»æã®å¡©åºã®åŠã匷塩åºãš
åå¿ããããšãå¡©ã®åœ¢ç¶ã§ãªããå³ã¡å¡©åºã®åœ¢ç¶
ã®åŒïŒïŒã®ååç©ãžå€åããã åŒïŒXIIïŒã®ãã€ããã¯ããªãã¯åŒïŒïŒã®å¡©åº
ã«è»¢ååŸåŸæ¥æ¹æ³ã§ãã®å¡©åºãå¡©åããããšã«ã
ã€ãŠçš®ã ã®å¡©ã«å€æããåŸãã åŒïŒïŒã®ååç©åã¯ãã®å¡©ã®è£œé ã«çšããã
ã奜ãŸããã¢ãã³ããäžèšã«ç€ºãã ãžã¡ãã«ã¢ããâãšãã«ã¢ãã³ã ãžãšãã«ã¢ããâãšãã«ã¢ãã³ã ãããªãžãâãšãã«ã¢ãã³ã ãããªãžãâãšãã«ã¢ãã³ã ã¢ã«ããªãâãšãã«ã¢ãã³ã ãžã¡ãã«ã¢ããâãããã«ã¢ãã³ã ãžãšãã«ã¢ããâãããã«ã¢ãã³ã ãããªãžãâãããã«ã¢ãã³ã ïŒâïŒïŒâã¡ãã«ãããªãžãïŒâãããã«ã¢ã
ã³ã ã¢ã«ããªãâãããã«ã¢ãã³ã ããã€ãã®ã¹ã«ãã¯ããªãåã³æ°èŠãªãã³ãŒã³
ã¹ã«ãã³ã¢ããã®è£œé ã«é¢ããäžèšã®ééå®çå®
æœäŸã«ãããæ¬çºæã説æããã å®æœäŸ ïŒ ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ããã«ã¯ããª
ãã®è£œé ããã¯C.M.SUTERåã³H.L.HANSENãJ.of
Am.Chem.Soc.1933ã55ã2080ã«å ±åããæ¹æ³ã«
åŸã€ãŠãïŒæ®µéã§è¡ãããã 第ïŒæ®µéïŒïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³
é žã«ãªãŠã ã®è£œé ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³85ïœïŒ0.615ã¢ã«ïŒ
ãã枩床èšã滎äžæŒæåã³ç£æ°æ¹æã·ã¹ãã ãå
ããäžéŠãã©ã¹ã³ïŒ250cm3ïŒã®äžã«å°å ¥ãããçŽ
ïŒâã«å·åŽåŸãç¡«é žïŒïœïŒ1.83â1.84ïŒ50cm3ïŒ0.9
ã¢ã«ïŒãäžæ»Žãã€å ããã次ã«æ··åç©ã宀枩ã«ã
ãŠ1.5æéæŸçœ®ãããåºåããåå¿æ··åç©ãçé ž
ã«ãªãŠã ã®é£œå溶液ïŒ138ïœïŒïŒ750cm3äžã«æ³šå ¥
åŸãäžæ©æŸçœ®ãããåŸãããæ²æ®¿ç©ãéåŸãªã³
æžå§ïŒCphosphoric vocuumïŒäžã§ä¹Ÿç¥ãããã åç 79ïŒ ç¬¬ïŒæ®µéïŒïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã
ã«ã¯ããªããžã®è»¢å ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³é žã«ãªãŠ
ã 124ïœïŒ0.484ã¢ã«ïŒãšããžã¡ãã«ãã«ã ã¢ãã
500cm3ãšããæ¹æã·ã¹ãã ãšå¡©åã«ã«ã·ãŠã ãã©
ãããšãåããäžéŠãã©ã¹ã³ïŒïŒãªããã«ïŒäžã«
é 次å°å ¥ãããåŸãããæžæ¿æ¶²ã«å¡©åããªãã«
69.5ïœïŒ0.583ã¢ã«ïŒã宀枩ã§ïŒæ»Žãã€å ããã
äžæ©æŸçœ®åŸãæ··åç©ãç ããæ°·ã«æ³šå ¥ãããåŸã
ããçœè²æ²æ®¿ç©ãè±æ°ŽåŸæ°Žã§ååæŽæµããŠãããª
ã³æžå§äžã§ä¹Ÿç¥ããã åç 75ïŒ ãmp72âïŒlitt.70.5âïŒ å®æœäŸ ïŒ ïŒïŒïŒïŒïŒâããªã¡ããã·ãã³ãŒã³ã¹ã«ããã«
ã¯ããªãã®è£œé ãã®è£œé ã¯ïŒã€ã®å·¥çšã«ãã€ãŠè¡ãããšãã§ã
ãã 第ïŒå·¥çš 枩床èšã滎äžæãå¡©åã«ã«ã·ãŠã ãã©ããå
ã³ç£æ°æ¹æã·ã¹ãã ãåãã500cm3äžã€å£ãã©ã¹
ã³ã«ã42ïœïŒ0.25ã¢ã«ïŒã®ïŒïŒïŒïŒïŒâããªã¡ã
ãã·ãã³ãŒã³ã®çŽç²ãªã¯ãããã«ã 200cm3溶液ã
å ¥ãããçªçŽ é°å²æ°äžã§â10âãŸã§å·åŽãããå
å¿åªè³ªã«ãã¯ããã¹ã«ãã³é ž80cm3ã滎äžæ·»å ã
ããã¯ãªãŒã ããã€ãçœè²ã®ãã«ã¯ç¶æ²æ®¿ãé 次
圢æããã次ãã§ç·è²ã®æº¶æ¶²ã¯è€è²ã«å€åããã
æ·»å ãå®äºããæã«ããã®åå¿åªè³ªã宀枩ã«ïŒæ
éæŸçœ®ãã次ã«ç Žç ããæ°·äžã«æ³šãã ãåŸããã
æ²æ®¿ãã¯ãããã«ã ã§æœåºãã次ã«ææ©çžãç¡«é ž
ãããªãŠã ã§ä¹Ÿç¥ãã次ãã§æžå§äžã§èžçºãã
ããç°è€è²ã®åºäœãçæãããŸã§ã圢æãããè€
è²æ®çç©ãæå°éã®ãã«ãšã³ã§æŽæ»ããã次ã«ã
ã®åºäœãã·ãªã«ã«ã©ã ã§ã¯ãããã°ã©ãåŠçã
ãã ãã³ãŒã³ã§æº¶åºããã次ã«ãã³ãŒã³âã¯ããã
ã«ã ïŒ50â50ïŒæ··åç©ã§æº¶åºããŠïŒïŒïŒïŒïŒâã
ãªã¡ããã·ãã³ãŒã³ã¹ã«ããã«ã¯ããªããåŸãã åç 46ïŒ ãmp147â NMRïŒCDCl3ïŒã80MHzïŒ ÎŽ7.29ppmïŒïœã1HãArHïŒïŒÎŽ6.55ppmïŒïœã
1HãArHïŒïŒÎŽ3.93ã3.78åã³3.53ppmïŒ3aã
9HãOCH3ïŒãIRïŒKBrïŒïŒÎœSO2ã1350cm-1
ïŒasïŒã1160cm-1ïŒïœïŒã 第ïŒå·¥çš ãã®å·¥çšã¯ïŒã€ã®ã¹ããããããªãã ïŒïŒïŒâãžã¡ããã·ã¯ãããã³ãŒã³ïŒ ç£æ°æ¹æã·ã¹ãã ã枩床èšãå¡©åã«ã«ã·ãŠã ã
ã©ããåã³æ»ŽäžæãåããïŒäžã€å£ãã©ã¹ã³
ã«ãïŒâã«å·åŽãããã©ãããŒã«138ïœïŒïŒã¢ã«ïŒ
ãç¶ç¶ããŠå°å ¥ãã次ã«ã¹ã«ããªã«ã¯ããªã135
ïœïŒïŒã¢ã«ïŒã滎äžãããæ·»å ãçµäºãããšã
ã«ãåå¿åªè³ªã宀枩ã«ãã次ãã§ïŒæéé眮åŸã
æžå§äžã§èžçããã åç 83ïŒ ãb.p.120âã1999.83ãã¹ã«ã«ïŒ15
mmHgïŒã ïŒïŒïŒâãžã¡ããã·âïŒâãããã¯ãããã³ãŒ
ã³ïŒ ç£æ°æ¹æã·ã¹ãã ã枩床èšãåã³æ»Žäžæãå
ããïŒäžã€å£ãã©ã¹ã³ã«ïŒïŒïŒâãžã¡ããã·ã¯
ãããã³ãŒã³143.9ïœïŒ0.83ã¢ã«ïŒãç¶ç¶ããŠå°
å ¥ãã次ã«æž©åºŠã25âãè¶ããªãããã«ããŠç¡é ž
ïŒïœïŒ1.38ïŒ166cm3ã滎äžãããæ·»å çµäºæã«ãå
å¿æ··åç©ã1.5æéé眮ãã次ãã§éããã åç 95ïŒ ãm.p.105â ïŒïŒïŒïŒïŒâããªã¡ããã·ããããã³ãŒã³ïŒ å·åŽè£ 眮ãåããïŒãã©ã¹ã³ã«ãæ°Žé žåã«ãª
ãŠã ã®ã¡ã¿ããŒã«æº¶æ¶²ïŒã¡ã¿ããŒã«500cm3äžã«
KOH100ïœïŒãç¶ç¶ããŠå°å ¥ãã次ã«ïŒïŒïŒâãž
ã¡ããã·âïŒâãããã¯ãããã³ãŒã³100ïœ
ïŒ0.46ã¢ã«ïŒãšã«ãŒãã©ã³ãã ãå°å ¥ããããã®
æ··åç©ãéæµäžã§ïŒæé沞隰ããããå·åŽåŸãå
å¿åªè³ªãéããåŸãããæ²æ®¿ãã¡ã¿ããŒã«ã§æŽ
æ»ããã åç 95ïŒ ãm.p.129â ïŒïŒïŒïŒïŒâããªã¡ããã·ã¢ããªã³ïŒ å·åŽè£ 眮ãåãã500cm3ãã©ã¹ã³ã«ãïŒïŒïŒïŒ
ïŒâããªã¡ããã·ããããã³ãŒã³21.3ïœïŒ0.1ã¢
ã«ïŒãéå±é¡çæçšã®ååŠçã«çŽç²ãªå¡©å第ïŒé«
80ïœãå¡©é žæº¶æ¶²ïŒïœïŒ1.18ïŒ100cm3åã³ã«ãŒãã©
ã³ãã ãé 次添å ããããã®æ··åç©ãïŒæééæµ
äžã§æ²žéš°ããããå·åŽåŸãæ²æ®¿ã溶解ãããŸã§è
æ§ãœãŒã溶液ãæ·»å ãããåŸããã溶液ãå¡©åã¡
ãã¬ã³ã§æœåºãããææ©æœåºç©ãç¡«é žãããªãŠã
ã§ä¹Ÿç¥ãã次ã«æžå§äžã§èžçºããããåŸãããæ®
çç©ããšã¿ããŒã«äžã§æ¶åºãããã åç 80ïŒ ïŒm.p.94â ïŒïŒïŒïŒïŒâããªã¡ããã·ãã³ãŒã³ã¹ã«ããã«
ã¯ããªãïŒ æ¹æã·ã¹ãã åã³æž©åºŠèšãåãã250cm3ã®äžã€
å£ãã©ã¹ã³ã«ãïŒïŒïŒïŒïŒâããªã¡ããã·ã¢ããª
ã³18.3ïœïŒ0.1ã¢ã«ïŒãå°å ¥ãã次ãã§å¡©é žæº¶æ¶²
ïŒïœïŒ1.18ïŒ50cm3ãå°å ¥ãããïŒæéæŸçœ®åŸãäº
ç¡é žãããªãŠã 溶液ïŒæ°Ž50cm3ã«NaNO210ïœïŒã
æ·»å ããŠãã®ã¢ãã³ãâïŒâã§ãžã¢ãŸåãããåŸ
ããããžã¢ãŸããŠã å¡©ãã40âã«å ç±ããçªçŽ é°
å²æ°äžã«ãããäºé žåç¡«é»ã§é£œåããé ¢é ž200cm3
ãšå¡©å第äºé ïŒïœãšãå«æããäžã€å£ãã©ã¹ã³ã«
åŸã ã«æ³šãã ãæ··åç©ãïŒæé60âã«ä¿æãã次
ãã§ç Žç ããæ°·äžã«æ³šãã ã åç 35ïŒ ïŒm.p.147â å®æœäŸ ïŒ ïŒâã¯ããâïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«
ããã«ã¯ããªãã®è£œé ãã®è£œé ã¯ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ããïŒ
ã€ã®ã¹ãããã§è¡ãããã 第ïŒã¹ãããïŒïŒïŒïŒâãžã¡ããã·ã¯ãããã³ãŒ
ã³ã®è£œé ãã®è£œé ã¯Annali di Chimicaã43å·»ã293é
ïŒ1953幎ïŒã«G.Castelfranchiåã³G.Borraãå ±å
ããæ¹æ³ã«åŸã€ãŠè¡ãããã ç£æ°æ¹æã·ã¹ãã ã枩床èšãå¡©åã«ã«ã·ãŠã ã
ã©ããåã³æ»Žäžæãåãã10âã«å·åŽãã500
cm3äžã€å£ãã©ã¹ã³ã«ãïŒïŒïŒâãžã¡ããã·ãã³ãŒ
ã³97.5ïœïŒ0.70ã¢ã«ïŒãç¶ç¶ããŠå°å ¥ãã次ãã§
ã¹ã«ããªã«ã¯ãã©ã€ã96.5ïœïŒ0.70ã¢ã«ïŒã滎äž
ãããæ·»å çµäºãšåæã«ã溶液ã宀枩ã«ãã©ã
ãŠãïŒæéæŸçœ®ã次ã«èžçããã åç 85ïŒ ãb.p.137âã2399.80ãã¹ã«ã«ïŒ18
mmHgïŒãã 第ïŒã¹ãããïŒïŒâã¯ããâïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ããã«ã¯ãã©ã€ããžã®è»¢
å ç£æ°æ¹æã·ã¹ãã ãå¡©åã«ã«ã·ãŠã ãã©ããã
枩床èšåã³æ»Žäžæãåãã500cm3äžã€å£ãã©ã¹
ã³ã«ã35ïœïŒ0.2ã¢ã«ïŒã®ïŒïŒïŒâãžã¡ããã·ã¯
ãããã³ãŒã³ã®250cm3ã®çŽç²ãªã¯ãããã«ã 溶液
ãå°å ¥ããã溶液ãïŒâã«å·åŽãã次ã«ã¯ããã¹
ã«ãã³é ž50cm3ïŒ0.75ã¢ã«ïŒã滎å è¿œå ãããæ·»å
çµäºãšåæã«ãåå¿åªè³ªã宀枩ã«æ»ãã次ã«ïŒæ
éæŸçœ®åŸãç Žç ããæ°·ã®äžã«æ³šãã ãåŸãããæ··
åç©ãã¯ãããã«ã ã§æœåºãããææ©æœåºç©ãç¡«
é žãããªãŠã ã§ä¹Ÿç¥ãã次ãã§æ¿çž®ããŠæ¶åºãã
ããåŸãããåºäœããšãã«ãšãŒãã«ïŒãã³ãŒã³æ··
åç©ããåçµæ¶ãããã åç 74ïŒ ãm.p.175â NMRïŒCDCl3ïŒã80MHzïŒ ÎŽ7.87ppmïŒïœã1HãArHïŒïŒÎŽ6.55ppmïŒïœã
1HãArHïŒïŒÎŽ4åã³3.96ppmïŒ2sã6Hã
OCH3ïŒ 1RïŒKBrïŒïŒÎœSO2ã1385cm-1ïŒasïŒã1170cm-1
ïŒïœïŒ å®æœäŸ ïŒ ïŒâããã¢âïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«
ããã«ã¯ããªãã®è£œé ãã®è£œé ã¯ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ããïŒ
ã€ã®ã¹ãããã§è¡ã€ãã 第ïŒã¹ãããïŒïŒïŒïŒâãžã¡ããã·ããã¢ãã³ãŒ
ã³ã®è£œé ãã®è£œé ã¯Hsu^eh Paoã25å·»ã277é ïŒ1959
幎ïŒã«S.T.Fengåã³K.Y.Chiuãå ±åããæ¹æ³ã«
åŸã€ãŠè¡ãããã ç£æ°æ¹æã·ã¹ãã åã³æž©åºŠèšãåãã10âã«å·
åŽãã250cm3ã®äžã€å£ãã©ã¹ã³ã«ãïŒïŒïŒâãžã¡
ããã·ãã³ãŒã³27.6ïœïŒ0.2ã¢ã«ïŒãç¶ç¶ããŠå
ãã次ã«ïŒ®âããã¢ã¹ã¯ã·ã³ã€ãã36ïœïŒ0.2ã¢
ã«ïŒãå°éã¥ã€æ·»å ãããæ·»å çµäºåŸçŽã¡ã«ãå
å¿åªè³ªã宀枩ã«æ»ããŠïŒæéæŸçœ®ãããæ°Žã§æŽæ»
ããŠã¯ãããã«ã ã§æœåºããåŸãææ©æœåºç©ãç¡«
é žãããªãŠã ã§ä¹Ÿç¥ãã次ãã§æžå§äžã§æ¿çž®ã
ããæ®ç液äœãèžçããã åç 82ïŒ ãb.p.150âã1999.83ãã¹ã«ã«ïŒ15
mmHgïŒã 第ïŒã¹ãããïŒïŒâããã¢âïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ããã«ã¯ããªããžã®è»¢å ïŒâã¯ããâïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«
ããã«ã¯ããªãã補é ããå®æœäŸïŒã«èšèŒãããš
åãæ¹æ³ã§è£œé ããããïŒïŒïŒâãžã¡ããã·ãã
ã¢ãã³ãŒã³65.1ïœãžïŒ0.3ã¢ã«ïŒãšã¯ããã¹ã«ã
ã³é ž100cm3ãçšãããåçã¯77ïŒ ã§ãã€ãã m.p.195â NMRïŒCDCl3ïŒã60MHz ÎŽ7.85ppmïŒïœã1HãArHïŒïŒ6.70ppmïŒïœã1Hã
ArHïŒïŒÎŽ3.92åã³3.88ppmïŒ2sã6Hã
OCH3ïŒïŒ IRïŒKBrïŒïŒÎœSO2ã1385cm-1ïŒasïŒã1165cm-1
ïŒïœïŒ å®æœäŸ ïŒ ïŒâã¢ã«ãã«ã¹ã«ããã«âïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ããã«ã¯ããªã ãããå¡©åç©ã¯ãå®æœäŸïŒã«èšèŒã®ïŒïŒïŒâãž
ã¡ããã·ãã³ãŒã³ã¹ã«ããã«ã¯ããªãããåŸãã
ãããããã補é ããããã®äžè¬çãªåå¿ãã€ã¢
ã°ã©ã ã¯äžèšã®éãã§ããã ïŒïŒïŒâãžã¡ããã·ãã³ãŒã«ã¹ã«ãã€ã³é ž ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ããã«ã¯ããª
ã115ïœïŒ0.487ã¢ã«ïŒãå°éãã€æ¹æããªããã
äºç¡«é žãããªãŠã 129ïœïŒ0.974ã¢ã«ïŒãå«ã氎溶
液ã«æ·»å ããããã®æäœäžã«ãèæ§ãœãŒããæ·»å
ããããšã«ãã€ãŠPHãã¢ã«ã«ãªæ§ã«ä¿æãããïŒ
æéé眮ããåŸãåå¿æ··åç©ãéãããã¹ã«ã
ã€ã³é žãæ²æ®¿ãããŸã§ã液ã2Nç¡«é žã§é žæ§å
ããã åç 72ïŒ ãm.p.122â ïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã€ã³é žãã
ãªãŠã ïŒ ååŠéè«éã®æ°Žé žåãããªãŠã ãå«æãã氎溶
液ãæ·»å ããããšã«ãã€ãŠãïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ãã€ã³é žãããªãŠã ãåŸãããã®ã¹
ã«ãã€ã³é žå¡©æº¶æ¶²ãèžçºä¹Ÿæ¶žããã ïŒïŒïŒïŒâãžã¡ããã·ããšãã«ïŒã¢ã«ãã«ã¹ã«
ãã³ äžè¬çæ¹æ³ïŒ å·åŽã·ã¹ãã ãšç£æ°æ¹æã·ã¹ãã ãåãã500
cm3ãã©ã¹ã³ã«ãïŒïŒïŒâãžã¡ããã·âãã³ãŒã³ã
ã«ãã³é žãããªãŠã 0.1ã¢ã«ãã€ãœãããããŒã«
250cm3åã³ããã²ã³åã¢ã«ãã«ã奜ãŸããã¯æ²å
ã¢ã«ãã«0.15ã¢ã«ãé 次添å ãããçšããããã
ãã²ã³åç©ã«å¿ããŠãã®æ··åç©ãïŒã30æééæµ
äžã§æ²žéš°ããããå·åŽåŸãåå¿åªè³ªãèžçºä¹Ÿåºã
ããæ®çç©ãæ°Žäžã«åãåºãã次ã«ã¯ãããã«ã
ã§æœåºãããç¡«é žãããªãŠã ã§ä¹Ÿç¥ããåŸãææ©
çžãèžçºãããŠãªã€ã«ãåŸãããã®ãªã€ã«ããã³
ãŒã³äžã§æ¶åºãããã
ãè¡šã
ïŒâã¢ã«ãã«ã¹ã«ããã«âïŒïŒïŒâãžã¡ããã·
ãã³ãŒã³ã¹ã«ããã«ã¯ããªã äžè¬çæ¹æ³ïŒ ç£æ°æ¹æã·ã¹ãã ãå¡©åã«ã«ã·ãŠã ãã©ããã
枩床èšåã³æ»ŽäžæãåããïŒã®äžã€å£ãã©ã¹
ã³ã«ãïŒïŒïŒïŒâãžã¡ããã·ããšãã«ïŒã¢ã«ãã«
ã¹ã«ãã³ïŒ0.2ã¢ã«ïŒã®çŽç²ãªãã³ãŒã³200cm3溶液
ãå°å ¥ãããâ10âã«å·åŽåŸãã¯ããã¹ã«ãã³é ž
100cm3ã滎äžæ·»å ãããæ·»å çµäºåŸãæ··åç©â10
âã§0.5æéé眮ãã次ã«å®€æž©ã«æ»ããïŒæéæ¹
æããã次ã«æ··åç©ãç Žç ããæ°·äžã«æ³šãã ãåŸ
ãããæ··åç©ãã¯ãããã«ã ã§æœåºãããææ©çž
ãç¡«é žãããªãŠã ã§ä¹Ÿç¥ããéãã次ã«æžå§äž
ã§èžçºãããæ®çç©ããã³ãŒã³äžã§æ¶åºãããã
ãã³ãŒã³ã¹ã«ããã«ã¯ããªã äžè¬çæ¹æ³ïŒ ç£æ°æ¹æã·ã¹ãã ãå¡©åã«ã«ã·ãŠã ãã©ããã
枩床èšåã³æ»ŽäžæãåããïŒã®äžã€å£ãã©ã¹
ã³ã«ãïŒïŒïŒïŒâãžã¡ããã·ããšãã«ïŒã¢ã«ãã«
ã¹ã«ãã³ïŒ0.2ã¢ã«ïŒã®çŽç²ãªãã³ãŒã³200cm3溶液
ãå°å ¥ãããâ10âã«å·åŽåŸãã¯ããã¹ã«ãã³é ž
100cm3ã滎äžæ·»å ãããæ·»å çµäºåŸãæ··åç©â10
âã§0.5æéé眮ãã次ã«å®€æž©ã«æ»ããïŒæéæ¹
æããã次ã«æ··åç©ãç Žç ããæ°·äžã«æ³šãã ãåŸ
ãããæ··åç©ãã¯ãããã«ã ã§æœåºãããææ©çž
ãç¡«é žãããªãŠã ã§ä¹Ÿç¥ããéãã次ã«æžå§äž
ã§èžçºãããæ®çç©ããã³ãŒã³äžã§æ¶åºãããã
ãè¡šã
ïŒïŒïŒâãžã¡ããã·âïŒâã¡ãã«ã¹ã«ããã«ã
ã³ãŒã³ã¹ã«ããã«ã¯ããªã NMRïŒDMSOïŒã80MHzïŒ ÎŽ8.2ppmïŒïœã1HãArHïŒïŒÎŽ6.9ppmïŒïœã
1HãArHïŒïŒÎŽ4.1ppmåã³4.05ppmïŒ2sã6Hã
OCH3ïŒïŒ3.2ppmïŒïœã3HãCH3ïŒ IRïŒKBrïŒïŒ ÎœSO2âClã1360cm-1ïŒasïŒã1170cm-1ïŒïœïŒïŒ
ÎœSO2âCH3ã1300cm-1ïŒasïŒã1140cm-1ïŒïœïŒïŒ ïŒâãšãã«ã¹ã«ããã«âïŒïŒïŒâãžã¡ããã·ã
ã³ãŒã³ã¹ã«ããã«ã¯ããªã NMRïŒDMSOïŒã30MHzïŒ ÎŽ8.2ppmïŒïœã1HãArHïŒïŒÎŽ6.93ppmïŒïœã
1HãArHïŒïŒÎŽ4.15ppmåã³4.1ppmïŒ2sã6Hã
OCH3ïŒïŒÎŽ3.25ppmïŒïœã2HãâCH2âïŒïŒ
ÎŽ1.18ppmïŒïœã3HãCH3âïŒ IRïŒKBrïŒïŒ ÎœSO2âClã1370cm-1ïŒasïŒã1175cm-1ïŒïœïŒïŒ
ÎœSO2âCH2âã1315cm-1ïŒasïŒã1140cm-1
ïŒïœïŒïŒ ïŒïŒïŒâãžã¡ããã·âïŒâãããã«ã¹ã«ããã«
ãã³ãŒã³ã¹ã«ããã«ã¯ããªã NMRïŒDMSOïŒã80MHzïŒ ÎŽ8.05ppmïŒïœã1HãArHïŒïŒÎŽ6.72ppmïŒïœã
1HãArHïŒïŒ3.92åã³3.87ppmïŒ2sã6Hã
OCH3ïŒïŒÎŽ3.2ppmïŒïœã2HãâCH2âSO2
âïŒïŒÎŽ1.45ppmïŒïœã2HãâCH2âïŒïŒ
ÎŽ0.85ppmïŒïœã3HãCH3ïŒ IRïŒKBrïŒïŒ ÎœSO2Clã1370cm-1ïŒasïŒã1180cm-1ïŒïœïŒïŒ
ÎœSO2âCH2ã1315cm-1ïŒasïŒã1135cm-1ïŒïœïŒïŒ ïŒâã€ãœãããã«ã¹ã«ããã«âïŒïŒïŒâãžã¡ã
ãã·ãã³ãŒã³ã¹ã«ããã«ã¯ããªã NMRïŒDMSOïŒã80MHz ÎŽ8.02ppmïŒïœã1HãArHïŒïŒÎŽ6.7ppmïŒïœã
1HãArHïŒïŒÎŽ3.92åã³3.85ppmïŒ2sã6Hã
OCH3ïŒïŒÎŽ3.48ppmïŒïœã1HãâââïŒïŒ
ÎŽ1.11åã³1.03ppmïŒ2sã6HãCH3ïŒïŒ IRïŒKBrïŒïŒ ÎœSO2âClã1365cm-1ïŒasïŒã1175cm-1ïŒïœïŒïŒ
ÎœSO2âCHã1300cm-1ïŒasïŒã1130cm-1ïŒïœïŒïŒ å®æœäŸ ïŒ ïŒ®â眮æïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³
ã¢ããã®è£œé å¡©åã¡ãã¬ã³ïŒ40cm3ïŒãšã¡ã¿ããŒã«ïŒ10cm3ïŒã®
æ··åç©äžã®ãã³ã³ãŒã³ã¹ã«ããã«ã¯ããªã0.015
ã¢ã«æº¶æ¶²ã«ã0.015ã¢ã«ã®ãžã¢ã«ãã«ã¢ããã¢ã«
ãã«ã¢ãã³ã®å¡©åã¡ãã¬ã³10cm3溶液ãå ããã宀
æž©ã§æ¹æããŠïŒæéé眮åŸãåå¿æ··åç©ãèžçºä¹Ÿ
涞ããŠãæ°Ž50cm3äžã«åãåºããããã®æ°Žæº¶æ¶²ããš
ãã«ãšãŒãã«ã§æŽæ»ãã次ã«èžçºä¹Ÿæ¶žãããæ®ç
ç©ãã€ãœãããããŒã«ïŒã¡ã¿ããŒã«æ··åç©äžã§æ¶
åºããããææã®å Žåã«ã¯ãå¡©åºãžã®è»¢åã¯ãæ²
殿ãçæãããŸã§INèæ§ãœãŒããçšããŠå¡©é žå¡©
氎溶液ãåŠçããŠè¡ããããæ²æ®¿ãå¡©åã¡ãã¬ã³
ã§æœåºãããææ©æº¶æ¶²ã也ç¥ããåŸãæžå§äžã§èž
çºããããåŸãããå¡©åºããšãã«ãšãŒãã«ïŒç³æ²¹
ãšãŒãã«æ··åç©äžã§æ¶åºãããã ãã®ä»ã®ååç©ãåæ§ã«ããŠè£œé ãããããã
ãäžèšè¡šã«éããïŒããããã®ååç©ã®èç¹
ã¯ãä»èšããªããã°ããã€ããã¯ããªãã®èç¹ã§
ããïŒã
ã³ãŒã³ã¹ã«ããã«ã¯ããªã NMRïŒDMSOïŒã80MHzïŒ ÎŽ8.2ppmïŒïœã1HãArHïŒïŒÎŽ6.9ppmïŒïœã
1HãArHïŒïŒÎŽ4.1ppmåã³4.05ppmïŒ2sã6Hã
OCH3ïŒïŒ3.2ppmïŒïœã3HãCH3ïŒ IRïŒKBrïŒïŒ ÎœSO2âClã1360cm-1ïŒasïŒã1170cm-1ïŒïœïŒïŒ
ÎœSO2âCH3ã1300cm-1ïŒasïŒã1140cm-1ïŒïœïŒïŒ ïŒâãšãã«ã¹ã«ããã«âïŒïŒïŒâãžã¡ããã·ã
ã³ãŒã³ã¹ã«ããã«ã¯ããªã NMRïŒDMSOïŒã30MHzïŒ ÎŽ8.2ppmïŒïœã1HãArHïŒïŒÎŽ6.93ppmïŒïœã
1HãArHïŒïŒÎŽ4.15ppmåã³4.1ppmïŒ2sã6Hã
OCH3ïŒïŒÎŽ3.25ppmïŒïœã2HãâCH2âïŒïŒ
ÎŽ1.18ppmïŒïœã3HãCH3âïŒ IRïŒKBrïŒïŒ ÎœSO2âClã1370cm-1ïŒasïŒã1175cm-1ïŒïœïŒïŒ
ÎœSO2âCH2âã1315cm-1ïŒasïŒã1140cm-1
ïŒïœïŒïŒ ïŒïŒïŒâãžã¡ããã·âïŒâãããã«ã¹ã«ããã«
ãã³ãŒã³ã¹ã«ããã«ã¯ããªã NMRïŒDMSOïŒã80MHzïŒ ÎŽ8.05ppmïŒïœã1HãArHïŒïŒÎŽ6.72ppmïŒïœã
1HãArHïŒïŒ3.92åã³3.87ppmïŒ2sã6Hã
OCH3ïŒïŒÎŽ3.2ppmïŒïœã2HãâCH2âSO2
âïŒïŒÎŽ1.45ppmïŒïœã2HãâCH2âïŒïŒ
ÎŽ0.85ppmïŒïœã3HãCH3ïŒ IRïŒKBrïŒïŒ ÎœSO2Clã1370cm-1ïŒasïŒã1180cm-1ïŒïœïŒïŒ
ÎœSO2âCH2ã1315cm-1ïŒasïŒã1135cm-1ïŒïœïŒïŒ ïŒâã€ãœãããã«ã¹ã«ããã«âïŒïŒïŒâãžã¡ã
ãã·ãã³ãŒã³ã¹ã«ããã«ã¯ããªã NMRïŒDMSOïŒã80MHz ÎŽ8.02ppmïŒïœã1HãArHïŒïŒÎŽ6.7ppmïŒïœã
1HãArHïŒïŒÎŽ3.92åã³3.85ppmïŒ2sã6Hã
OCH3ïŒïŒÎŽ3.48ppmïŒïœã1HãâââïŒïŒ
ÎŽ1.11åã³1.03ppmïŒ2sã6HãCH3ïŒïŒ IRïŒKBrïŒïŒ ÎœSO2âClã1365cm-1ïŒasïŒã1175cm-1ïŒïœïŒïŒ
ÎœSO2âCHã1300cm-1ïŒasïŒã1130cm-1ïŒïœïŒïŒ å®æœäŸ ïŒ ïŒ®â眮æïŒïŒïŒâãžã¡ããã·ãã³ãŒã³ã¹ã«ãã³
ã¢ããã®è£œé å¡©åã¡ãã¬ã³ïŒ40cm3ïŒãšã¡ã¿ããŒã«ïŒ10cm3ïŒã®
æ··åç©äžã®ãã³ã³ãŒã³ã¹ã«ããã«ã¯ããªã0.015
ã¢ã«æº¶æ¶²ã«ã0.015ã¢ã«ã®ãžã¢ã«ãã«ã¢ããã¢ã«
ãã«ã¢ãã³ã®å¡©åã¡ãã¬ã³10cm3溶液ãå ããã宀
æž©ã§æ¹æããŠïŒæéé眮åŸãåå¿æ··åç©ãèžçºä¹Ÿ
涞ããŠãæ°Ž50cm3äžã«åãåºããããã®æ°Žæº¶æ¶²ããš
ãã«ãšãŒãã«ã§æŽæ»ãã次ã«èžçºä¹Ÿæ¶žãããæ®ç
ç©ãã€ãœãããããŒã«ïŒã¡ã¿ããŒã«æ··åç©äžã§æ¶
åºããããææã®å Žåã«ã¯ãå¡©åºãžã®è»¢åã¯ãæ²
殿ãçæãããŸã§INèæ§ãœãŒããçšããŠå¡©é žå¡©
氎溶液ãåŠçããŠè¡ããããæ²æ®¿ãå¡©åã¡ãã¬ã³
ã§æœåºãããææ©æº¶æ¶²ã也ç¥ããåŸãæžå§äžã§èž
çºããããåŸãããå¡©åºããšãã«ãšãŒãã«ïŒç³æ²¹
ãšãŒãã«æ··åç©äžã§æ¶åºãããã ãã®ä»ã®ååç©ãåæ§ã«ããŠè£œé ãããããã
ãäžèšè¡šã«éããïŒããããã®ååç©ã®èç¹
ã¯ãä»èšããªããã°ããã€ããã¯ããªãã®èç¹ã§
ããïŒã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ïŒ çµæã¯ãå¡©åºã®åœ¢ç¶ã®ååç©ã«é¢ããã
æ¬çºæã®æ°èŠãªãã³ãŒã³ã¹ã«ãã³ã¢ããåã³ã
ã®è¬å€äžèš±å®¹ãåŸãææ©åã¯ç¡æ©å¡©ã¯ãåªããè¬
ç掻æ§ãæããã æ¬çºæååç©ã¯äžæ¢ç¥çµç³»ã«å¯Ÿããã³ã³ãããŒ
ã«äœçšãç¹ã«ç²ŸçŽ³èª¿ç¯äœçšïŒpsychomodulator
reactionïŒãçºæ®ããããããååç©ã¯ãç¹ã«æ
ãã€å€ãŸãã¯äžå®è§£æ¶ãã©ã³ãã©ã€ã¶ãšããŠäœçš
ãåŸãããããååç©ã®æŽ»æ§ã¯ãè³éŠææ žã®ïŒäœ
ã«ååšããã¢ã«ã³ãã·åºã«ç±æ¥ããååã®èŠªæ²¹æ§
ã«ããå¢åŒ·ãããã æ¬çºæååç©ã¯ãã³ããã«ãã¿ãŒã«ç¡ç ãå¢åŒ·
ããéåžžããçš®ã®æãŸãããªãå¯äœçšïŒä¹³æŒçã
ç¡æçµãéäœå€è·¯ç䟯矀ïŒãçèµ·ãããšæããã
ãããã³äœçšæ§éšäœã«å¯Ÿãã芪ååãæ®ãã©æã
ãããŸãæ¯æ§ããªãã ãããååç©ã®æ²»çææ°ã¯ãå»è¬çšéã«é©åã
ãŠããã æ¬çºæååç©ã¯ãæãã€ãäžå®çç¶ã䌎ãç¹æ®
ãªç²Ÿç¥èº«äœã®ç°åžžãçèµ·ããçŸæ£ã®æ²»çã®éã®æŽ»
æ§æåãšããŠæäžãããã®ãæå©ã§ããã æ¬çºæååç©ã¯ãé å€ãç²å€ãã«ãã»ã«å€ã飲
æçšã¢ã³ãã«å€åã³æ³šå ¥çšæº¶æ¶²ã®è£œé çšã«ç¹ã«äœ¿
çšããã賊圢å€åã³åžžçšã®è£å©è¬ãšé åãããã æ¬çºæååç©ãå«æããåºè¬ã¯çµå£ãéçµå£ã
çŽè žåã¯å±æã«æäžãããã®ã奜ãŸãããæäžã
ãã掻æ§ååç©ã®çšéã¯å¥œãŸããã¯10ã700mgïŒ
dayãç¹ã«å¥œãŸããã¯50ã500mgïŒdayã§ããã æ¬çºæååç©ã®è¬çåŠçæ§è³ªã確èªããããã®
åçš®ãã¹ãã®ïŒäŸãšããŠãäžèšãã¹ããå ±åã
ãã æ¬çºæå»è¬ãšãã³ããã«ãã¿ãŒã«ãšã®çžäºäœçš
ã«é¢ãããã¹ã ãã¹ãåç©ãšããŠãLE GENESTã®é£Œè²ã»ã³
ã¿ãŒããæäŸãããäœé20â24ïœã®EOPS
SWISSéããŠã¹ãçšããã åç©ããã¹ãåå°ãªããšãïŒæ¥éãç 究æã®å
ç©å®€ã§éŠŽåãããã ïŒãã¹ãåã³ïŒçæç©åœã10å¹ã®ããŠã¹ãïŒçŸ€
ãšããã ã³ã³ãããŒã«ãã¹ããå®æœããããã®å¯Ÿç §ç©è³ª
ãšããŠãäžèšã®ååç©ã䜿çšããã âãïŒïŒâãšãã«âïŒâãããªãžãã«ïŒã¡ã
ã«ãïŒâã¡ããã·âïŒâã¹ã«ãã¢ã¢ã€ã«ãã³ã¶ã
ãïŒsulpirideã®å称ã§å ¬ç¥ã®ååç©ïŒã âãïŒïŒâãšãã«âïŒâãããªãžãã«ïŒã¡ã
ã«ãïŒâã¡ããã·âïŒâãšãã«ã¹ã«ããã«ãã³ã¶
ããïŒsultoprideã®å称ã§å ¬ç¥ã®ååç©ïŒã âïŒïŒâãžãšãã«ã¢ãã ãšãã«ïŒïŒâã¡ã
ãã·âïŒâã¡ãã«ã¹ã«ããã«ãã³ã¶ãã
ïŒtiaprideã®å称ã§å ¬ç¥ã®ååç©ïŒã æ¬çºæååç©åã³å¯Ÿç §ç©è³ªãã¢ã©ãã¢ãŽã ïŒïŒ
ïŒ ïŒæ°Žæº¶æ¶²ã«æžæ¿ãããåèšæ°Žæ§æžæ¿æ¶²ãçµå£æ
äžããïŒãã«ãããŒã«é žå¡©ãšã®çžäºäœçšã«å¯Ÿãã
ãã¹ãïŒã è¬çåŠçè©Šè¬ãå³ã¡ãã³ããã«ãã¿ãŒã«ãç匵
æ§NaCl溶液ã®åœ¢æ ã«ããŠæäžããã äœé20ïœããã1.6ïœïŒå«æãã溶液0.5mlã
è ¹è å æäžããïŒ40mgïŒKgïŒã ãããã®ãã¹ããå®æœããããã«ãïŒçŸ€10å¹ã®
SWISSéããŠã¹ã«æ¬çºæååç©åã¯å¯Ÿç §ç©è³ª
ïŒå³ã¡sulpirideãsultoprideåã¯tiaprideïŒã200
mgïŒKgã®æäžéã§çµå£æäžãããæ¬çºæååç©å
ã¯å¯Ÿç §ç©è³ªãæäž60ååŸã«ããã³ã³ããã«ãã¿ãŒ
ã«ãNEMBUTALã®åååã§åžè²©ãããŠããåŠ
ããããªãŠã å¡©ã®åœ¢æ ã§åç©ã«æäžãããããšã
ãšç¶æ æéïŒdrowsiness timeïŒåã³ç¡ç æé
ïŒsleeping timeïŒã枬å®ããæŽã«ç¡ç æéã®å€å
çãã枬å®ããããã¹ãçµæãäžèšç¬¬è¡šã«ç€º
ãã
æ¬çºæã®æ°èŠãªãã³ãŒã³ã¹ã«ãã³ã¢ããåã³ã
ã®è¬å€äžèš±å®¹ãåŸãææ©åã¯ç¡æ©å¡©ã¯ãåªããè¬
ç掻æ§ãæããã æ¬çºæååç©ã¯äžæ¢ç¥çµç³»ã«å¯Ÿããã³ã³ãããŒ
ã«äœçšãç¹ã«ç²ŸçŽ³èª¿ç¯äœçšïŒpsychomodulator
reactionïŒãçºæ®ããããããååç©ã¯ãç¹ã«æ
ãã€å€ãŸãã¯äžå®è§£æ¶ãã©ã³ãã©ã€ã¶ãšããŠäœçš
ãåŸãããããååç©ã®æŽ»æ§ã¯ãè³éŠææ žã®ïŒäœ
ã«ååšããã¢ã«ã³ãã·åºã«ç±æ¥ããååã®èŠªæ²¹æ§
ã«ããå¢åŒ·ãããã æ¬çºæååç©ã¯ãã³ããã«ãã¿ãŒã«ç¡ç ãå¢åŒ·
ããéåžžããçš®ã®æãŸãããªãå¯äœçšïŒä¹³æŒçã
ç¡æçµãéäœå€è·¯ç䟯矀ïŒãçèµ·ãããšæããã
ãããã³äœçšæ§éšäœã«å¯Ÿãã芪ååãæ®ãã©æã
ãããŸãæ¯æ§ããªãã ãããååç©ã®æ²»çææ°ã¯ãå»è¬çšéã«é©åã
ãŠããã æ¬çºæååç©ã¯ãæãã€ãäžå®çç¶ã䌎ãç¹æ®
ãªç²Ÿç¥èº«äœã®ç°åžžãçèµ·ããçŸæ£ã®æ²»çã®éã®æŽ»
æ§æåãšããŠæäžãããã®ãæå©ã§ããã æ¬çºæååç©ã¯ãé å€ãç²å€ãã«ãã»ã«å€ã飲
æçšã¢ã³ãã«å€åã³æ³šå ¥çšæº¶æ¶²ã®è£œé çšã«ç¹ã«äœ¿
çšããã賊圢å€åã³åžžçšã®è£å©è¬ãšé åãããã æ¬çºæååç©ãå«æããåºè¬ã¯çµå£ãéçµå£ã
çŽè žåã¯å±æã«æäžãããã®ã奜ãŸãããæäžã
ãã掻æ§ååç©ã®çšéã¯å¥œãŸããã¯10ã700mgïŒ
dayãç¹ã«å¥œãŸããã¯50ã500mgïŒdayã§ããã æ¬çºæååç©ã®è¬çåŠçæ§è³ªã確èªããããã®
åçš®ãã¹ãã®ïŒäŸãšããŠãäžèšãã¹ããå ±åã
ãã æ¬çºæå»è¬ãšãã³ããã«ãã¿ãŒã«ãšã®çžäºäœçš
ã«é¢ãããã¹ã ãã¹ãåç©ãšããŠãLE GENESTã®é£Œè²ã»ã³
ã¿ãŒããæäŸãããäœé20â24ïœã®EOPS
SWISSéããŠã¹ãçšããã åç©ããã¹ãåå°ãªããšãïŒæ¥éãç 究æã®å
ç©å®€ã§éŠŽåãããã ïŒãã¹ãåã³ïŒçæç©åœã10å¹ã®ããŠã¹ãïŒçŸ€
ãšããã ã³ã³ãããŒã«ãã¹ããå®æœããããã®å¯Ÿç §ç©è³ª
ãšããŠãäžèšã®ååç©ã䜿çšããã âãïŒïŒâãšãã«âïŒâãããªãžãã«ïŒã¡ã
ã«ãïŒâã¡ããã·âïŒâã¹ã«ãã¢ã¢ã€ã«ãã³ã¶ã
ãïŒsulpirideã®å称ã§å ¬ç¥ã®ååç©ïŒã âãïŒïŒâãšãã«âïŒâãããªãžãã«ïŒã¡ã
ã«ãïŒâã¡ããã·âïŒâãšãã«ã¹ã«ããã«ãã³ã¶
ããïŒsultoprideã®å称ã§å ¬ç¥ã®ååç©ïŒã âïŒïŒâãžãšãã«ã¢ãã ãšãã«ïŒïŒâã¡ã
ãã·âïŒâã¡ãã«ã¹ã«ããã«ãã³ã¶ãã
ïŒtiaprideã®å称ã§å ¬ç¥ã®ååç©ïŒã æ¬çºæååç©åã³å¯Ÿç §ç©è³ªãã¢ã©ãã¢ãŽã ïŒïŒ
ïŒ ïŒæ°Žæº¶æ¶²ã«æžæ¿ãããåèšæ°Žæ§æžæ¿æ¶²ãçµå£æ
äžããïŒãã«ãããŒã«é žå¡©ãšã®çžäºäœçšã«å¯Ÿãã
ãã¹ãïŒã è¬çåŠçè©Šè¬ãå³ã¡ãã³ããã«ãã¿ãŒã«ãç匵
æ§NaCl溶液ã®åœ¢æ ã«ããŠæäžããã äœé20ïœããã1.6ïœïŒå«æãã溶液0.5mlã
è ¹è å æäžããïŒ40mgïŒKgïŒã ãããã®ãã¹ããå®æœããããã«ãïŒçŸ€10å¹ã®
SWISSéããŠã¹ã«æ¬çºæååç©åã¯å¯Ÿç §ç©è³ª
ïŒå³ã¡sulpirideãsultoprideåã¯tiaprideïŒã200
mgïŒKgã®æäžéã§çµå£æäžãããæ¬çºæååç©å
ã¯å¯Ÿç §ç©è³ªãæäž60ååŸã«ããã³ã³ããã«ãã¿ãŒ
ã«ãNEMBUTALã®åååã§åžè²©ãããŠããåŠ
ããããªãŠã å¡©ã®åœ¢æ ã§åç©ã«æäžãããããšã
ãšç¶æ æéïŒdrowsiness timeïŒåã³ç¡ç æé
ïŒsleeping timeïŒã枬å®ããæŽã«ç¡ç æéã®å€å
çãã枬å®ããããã¹ãçµæãäžèšç¬¬è¡šã«ç€º
ãã
ãè¡šã
ãè¡šã
æ¬çºæã®æ°èŠãªäžçœ®æãã³ãŒã³ã¹ã«ãã³ã¢ãã
é¡ã¯ãç¹ã«å¥œãŸããååç©ã§ããäžã€å»è¬ãšãª
ãã äºçœ®æãã³ãŒã³ã¹ã«ãã³ã¢ããé¡ã¯èå³æ·±ãæ§
質ãæããŠããããåŸãããçµæãèæ ®ãããšã
R5ãæ°ŽçŽ ã§ãªãå Žåäžçœ®æãã³ãŒã³ã¹ã«ãã³ã¢
ããã®çç©åŠçæ§è³ªã¯å¯Ÿå¿ããäºçœ®æãã³ãŒã³ã¹
ã«ãã³ã¢ããã«æ¯ããŠåªããŠããããšãç¥èŠãã
ãŠããã åŸã€ãŠãã¢ã«ã³ãã·åºã«ããïŒïŒïŒäœã®äºçœ®æ
ãšïŒäœã®çœ®æãšã®çµåãããååã®å šäœã®æŽ»æ§ã®
ç¹ã§ç¹ã«æå©ã§ããã åŸãããçµæãããæ¬çºæååç©ã粟ç¥èª¿ç¯äœ
çšå€ã§ããããšãç¥èŠããããç¡ç æéã®å€åç
ãïŒ50ïŒ ä»¥äžã®ååç©ã¯ãæããã«ãã³ããã«ã
ã¿ãŒã«ç¡ç å¢åŒ·å€ã§ãããåŸã€ãŠãã©ã³ãã©ã€ã¶
ãŸãã¯äžå®è§£æ¶å€ãšããŠäœ¿çšããåŸãã ç¡ç æéã®å€åçãçŽïŒïŒ ä¹è³çŽ50ïŒ ã®æ¬çºæ
ååç©ã¯ãå¯Ÿç §ç©è³ªsultoprideãtiaprideã®è¿å
ã«æŒãã掻æ§å¢åŒ·å€ã§ããã ç¡ç æéã®å€åçãïŒïŒ æªæºã®æ¬çºæååç©ã¯
æ®æç©è³ªã§ãããæãã€å€ãšããŠäœ¿çšããåŸãã å¯Ÿç §ç©è³ªãšããŠäœ¿çšãããsulprideã¯ããèª
äœãç¥çµåŒç·©å€ãšæãã€å€ã®ïŒéã®ãããã€ãŒã«
ã瀺ãå¢åŒ·å€åã¯æ®æç©è³ªã§ããããšãç¥èŠãã
ãŠããã
é¡ã¯ãç¹ã«å¥œãŸããååç©ã§ããäžã€å»è¬ãšãª
ãã äºçœ®æãã³ãŒã³ã¹ã«ãã³ã¢ããé¡ã¯èå³æ·±ãæ§
質ãæããŠããããåŸãããçµæãèæ ®ãããšã
R5ãæ°ŽçŽ ã§ãªãå Žåäžçœ®æãã³ãŒã³ã¹ã«ãã³ã¢
ããã®çç©åŠçæ§è³ªã¯å¯Ÿå¿ããäºçœ®æãã³ãŒã³ã¹
ã«ãã³ã¢ããã«æ¯ããŠåªããŠããããšãç¥èŠãã
ãŠããã åŸã€ãŠãã¢ã«ã³ãã·åºã«ããïŒïŒïŒäœã®äºçœ®æ
ãšïŒäœã®çœ®æãšã®çµåãããååã®å šäœã®æŽ»æ§ã®
ç¹ã§ç¹ã«æå©ã§ããã åŸãããçµæãããæ¬çºæååç©ã粟ç¥èª¿ç¯äœ
çšå€ã§ããããšãç¥èŠããããç¡ç æéã®å€åç
ãïŒ50ïŒ ä»¥äžã®ååç©ã¯ãæããã«ãã³ããã«ã
ã¿ãŒã«ç¡ç å¢åŒ·å€ã§ãããåŸã€ãŠãã©ã³ãã©ã€ã¶
ãŸãã¯äžå®è§£æ¶å€ãšããŠäœ¿çšããåŸãã ç¡ç æéã®å€åçãçŽïŒïŒ ä¹è³çŽ50ïŒ ã®æ¬çºæ
ååç©ã¯ãå¯Ÿç §ç©è³ªsultoprideãtiaprideã®è¿å
ã«æŒãã掻æ§å¢åŒ·å€ã§ããã ç¡ç æéã®å€åçãïŒïŒ æªæºã®æ¬çºæååç©ã¯
æ®æç©è³ªã§ãããæãã€å€ãšããŠäœ¿çšããåŸãã å¯Ÿç §ç©è³ªãšããŠäœ¿çšãããsulprideã¯ããèª
äœãç¥çµåŒç·©å€ãšæãã€å€ã®ïŒéã®ãããã€ãŒã«
ã瀺ãå¢åŒ·å€åã¯æ®æç©è³ªã§ããããšãç¥èŠãã
ãŠããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒïŒïŒïŒ ïŒåŒäžã ïœåã³ïœã¯ããããå¥åã«ïŒãïŒã®å€ã§ããã R3åã³R4ã¯ããããå¥åã«ççŽ æ°ïŒãïŒã®äœ
çŽã¢ã«ãã«åºãè¡šãã R1åã³R2ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºãè¡šã
ããæãã¯çªçŽ ååãšçµåããŠïŒååã¯ïŒåã®çµ
åãæããçªçŽ å«æè€çŽ ç°åŒåºãç¹ã«ççŽ æ°ïŒã
ïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºã«ãã眮æã
ããŠãããæªçœ®æã®ãããªãžããã¢ã«ããªããã
ãã©ãžãã«ããããŒã«ãããã¯ãããªãžãåºã圢
æãã R5ã¯æ°ŽçŽ ååãããã²ã³ååãNO2åºãNH2
åºãCF3åºãççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºåã¯ç
çŽ æ°ïŒãïŒã®ã¢ã«ãã«ã¹ã«ããã«åºãè¡šãã R6åã³R7ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®ã¢ã«ãã«åºåã¯ççŽ æ°ïŒãïŒã®ã·ã¯ãã¢
ã«ãã«åºãè¡šãïŒ ãæããååç©äžŠã³ã«ãã®å¡©ã ïŒ äžè¬åŒïŒïŒïŒ ïŒåŒäžã ïœã¯ïŒåã¯ïŒã§ããã R3åã³R4ã¯ããããå¥åã«ççŽ æ°ïŒãïŒã®äœ
çŽã¢ã«ãã«åºãè¡šãã R1åã³R2ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºãè¡šã
ããæãã¯çªçŽ ååãšçµåããŠïŒååã¯ïŒåã®çµ
åãæããçªçŽ å«æè€çŽ ç°åŒåºãç¹ã«ççŽ æ°ïŒã
ïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºã«ãã眮æã
ããŠãããæªçœ®æã®ãããªãžããã¢ã«ããªããã
ãã©ãžãã«ããããŒã«ãããã¯ãããªãžãåºã圢
æãã R5ã¯æ°ŽçŽ ååãããã²ã³ååãNO2åºãNH2
åºãCF3åºãççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºåã¯ç
çŽ æ°ïŒãïŒã®ã¢ã«ãã«ã¹ã«ããã«åºãè¡šãïŒ ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©äžŠ
ã³ã«ãã®å¡©ã ïŒ äžè¬åŒïŒïŒïŒ ïŒåŒäžã ïœã¯ïŒåã¯ïŒã§ããã R5ã¯ïŒšãClãBrãOCH3ãSO2âCH3ãSO2â
C2H5ãSO2âïœâC3H7åã¯SO2âïœâC3H7ãè¡š
ãã ãåŒãã¯ãžã¡ãã«ã¢ããããžãšãã«ã¢ããã ãããªãžããã¢ã«ããªãããããªãžãåã³ç¹ã«ïŒ
äœãã¡ãã«åºã§çœ®æããããããªãžãåºãããªã
ã°ã«ãŒãããéžæãããåºãè¡šãïŒ ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©äžŠ
ã³ã«ãã®å¡©ã ïŒ ïœã¯ïŒåã¯ïŒã§ããã R5ã¯ïŒšãè¡šãã ãåŒãã¯ãžã¡ãã«ã¢ããããžãšãã«ã¢ããã ãããªãžããã¢ã«ããªãããããªãžãåã³ç¹ã«ïŒ
äœãã¡ãã«åºã§çœ®æããããããªãžãåºãããªã
ã°ã«ãŒãããéžæãããåºãè¡šãç¹èš±è«æ±ã®ç¯å²
第ïŒé ã«èšèŒã®ååç©äžŠã³ã«ãã®å¡©ã ïŒ ïœã¯ïŒåã¯ïŒã§ããã R5ã¯ClãBrãOCH3ãSO2âCH3ãSO2â
C2H5ãSO2âïœâC3H7åã¯SO2âïœâC3H7ãè¡š
ãã ãåŒãã¯ãžã¡ãã«ã¢ããããžãšãã«ã¢ããã ãããªãžããã¢ã«ããªãããããªãžãåã³ç¹ã«ïŒ
äœãã¡ãã«åºã§çœ®æããããããªãžãåºãããªã
ã°ã«ãŒãããéžæãããåºãè¡šãç¹èš±è«æ±ã®ç¯å²
第ïŒé ã«èšèŒã®ååç©äžŠã³ã«ãã®å¡©ã ïŒ äžè¬åŒïŒïŒïŒ ïŒåŒäžã ïœåã³ïœã¯ããããå¥åã«ïŒãïŒã®å€ã§ããã R3åã³R4ã¯ããããå¥åã«ççŽ æ°ïŒãïŒã®äœ
çŽã¢ã«ãã«åºãè¡šãã R1åã³R2ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºãè¡šã
ããæãã¯çªçŽ ååãšçµåããŠïŒååã¯ïŒåã®çµ
åãæããçªçŽ å«æè€çŽ ç°åŒåºãç¹ã«ççŽ æ°ïŒã
ïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºã«ãã眮æã
ããŠãããæªçœ®æã®ãããªãžããã¢ã«ããªããã
ãã©ãžãã«ããããŒã«ãããã¯ãããªãžãåºã圢
æãã R5ã¯æ°ŽçŽ ååãããã²ã³ååãNO2åºãNH2
åºãCF3åºãççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºåã¯ç
çŽ æ°ïŒãïŒã®ã¢ã«ãã«ã¹ã«ããã«åºãè¡šãã R6åã³R7ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®ã¢ã«ãã«åºåã¯ççŽ æ°ïŒãïŒã®ã·ã¯ãã¢
ã«ãã«åºãè¡šãïŒ ãæããååç©ã®ãã€ããã¯ããªãã®è£œé æ¹æ³ã§
ãã€ãŠã åŒïŒXIïŒïŒ ïŒåŒäžã ïœåã³ïœã¯ããããå¥åã«ïŒãïŒã®å€ã§ããã R1ãR2ãR6åã³R7ã¯åèšãšå矩ã§ããïŒ ãæããã¢ãã³ãšåŒïŒïŒïŒ ïŒåŒäžã R3åã³R4ã¯åèšãšå矩ã§ããã ã¯R5ãšå矩ã§ããããNH2ãé€ãïŒ ãæããã¹ã«ãã¯ããªããšãåå¿ãããŠäžè¬åŒ
ïŒïŒãæããååç©ã®ãã€ããã¯ããªããåŸã
ãã®åŸæèŠã«ãããNO2ãè¡šããšãã«ã¯éå
ããããšãããªã補é æ¹æ³ã ïŒ åŒïŒXIïŒãæããã¢ãã³ãã ãžã¡ãã«ã¢ãããšãã«ã¢ãã³ã ãžãšãã«ã¢ãããšãã«ã¢ãã³ã ãããªãžããšãã«ã¢ãã³ã ãããªãžããšãã«ã¢ãã³ã ã¢ã«ããªããšãã«ã¢ãã³ã ãžã¡ãã«ã¢ãããããã«ã¢ãã³ã ãžãšãã«ã¢ãããããã«ã¢ãã³ã ãããªãžããããã«ã¢ãã³ã ïŒâïŒïŒâã¡ãã«ãããªãžãïŒãããã«ã¢ã
ã³ãåã³ã¢ã«ããªããããã«ã¢ãã³ã ã®äžããéžæãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒ
ã®æ¹æ³ã ïŒ åŒïŒïŒãæããã¹ã«ãã¯ããªããäžèšã®ã¢
ãªãŒã«ã¢ãã³ïŒ ïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒâã¯ããâïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒâããã¢âïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒïŒïŒïŒïŒâããªã¡ããã·ã¢ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâã¡ãã«ã¹ã«ããã«ã¢
ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâãšãã«ã¹ã«ããã«ã¢
ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâïœâãããã«ã¹ã«ã
ãã«ã¢ããªã³ãå㯠ïŒïŒïŒâãžã¡ããã·âïŒâïœâãããã«ã¹ã«ã
ãã«ã¢ããªã³ã ããåŸãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ¹
æ³ã ïŒ äžè¬åŒïŒïŒïŒ ïŒåŒäžã ïœåã³ïœã¯ããããå¥åã«ïŒãïŒã®å€ã§ããã R3åã³R4ã¯ããããå¥åã«ççŽ æ°ïŒãïŒã®äœ
çŽã¢ã«ãã«åºãè¡šãã R1åã³R2ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºãè¡šã
ããæãã¯çªçŽ ååãšçµåããŠïŒååã¯ïŒåã®çµ
åãæããçªçŽ å«æè€çŽ ç°åŒåºãç¹ã«ççŽ æ°ïŒã
ïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºã«ãã眮æã
ããŠãããæªçœ®æã®ãããªãžããã¢ã«ããªããã
ãã©ãžãã«ããããŒã«ãããã¯ãããªãžãåºã圢
æãã R5ã¯æ°ŽçŽ ååãããã²ã³ååãNO2åºãNH2
åºãCF3åºãççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºåã¯ç
çŽ æ°ïŒãïŒã®ã¢ã«ãã«ã¹ã«ããã«åºãè¡šãã R6åã³R7ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®ã¢ã«ãã«åºåã¯ççŽ æ°ïŒãïŒã®ã·ã¯ãã¢
ã«ãã«åºãè¡šãïŒ ãæããååç©åã¯ãã®å¡©ã®è£œé æ¹æ³ã§ãã€ãŠã
åŒïŒXIïŒïŒ ïŒåŒäžã ïœåã³ïœã¯ããããå¥åã«ïŒãïŒã®å€ã§ããã R1ãR2ãR6åã³R7ã¯åèšãšå矩ã§ããïŒ ãæããã¢ãã³ãšåŒïŒïŒïŒ ïŒåŒäžã R3åã³R4ã¯åèšãšå矩ã§ããã ã¯R5ãšå矩ã§ããããNH2ãé€ãïŒ ãæããã¹ã«ãã¯ããªããšãåå¿ãããŠäžè¬åŒ
ïŒïŒãæããååç©ã®ãã€ããã¯ããªããåŸã åèšãã€ããã¯ããªãã察å¿ã®å¡©åºã«å€æãã
ãã®åŸæèŠã«ãããNO2ãè¡šããšãã«ã¯éå
ããããå㯠åèšãã€ããã¯ããªããå¥ã®å¡©ã«å€æãããã®
åŸæèŠã«ãããNO2ãè¡šããšãã«ã¯éå ãã
ããšãããªã補é æ¹æ³ã ïŒïŒ åŒïŒXIïŒãæããã¢ãã³ãã ãžã¡ãã«ã¢ãããšãã«ã¢ãã³ã ãžãšãã«ã¢ãããšãã«ã¢ãã³ã ãããªãžããšãã«ã¢ãã³ã ãããªãžããšãã«ã¢ãã³ã ã¢ã«ããªããšãã«ã¢ãã³ã ãžã¡ãã«ã¢ãããããã«ã¢ãã³ã ãžãšãã«ã¢ãããããã«ã¢ãã³ã ãããªãžããããã«ã¢ãã³ã ïŒâïŒïŒâã¡ãã«ãããªãžãïŒãããã«ã¢ã
ã³ãåã³ã¢ã«ããªããããã«ã¢ãã³ã ã®äžããéžæãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒ
ã®æ¹æ³ã ïŒïŒ åŒïŒïŒãæããã¹ã«ãã¯ããªããäžèšã®
ã¢ãªãŒã«ã¢ãã³ïŒ ïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒâã¯ããâïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒâããã¢âïŒïŒïŒâãžã¡ããã·ã¢ããªã³ã ïŒïŒïŒïŒïŒâããªã¡ããã·ã¢ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâã¡ãã«ã¹ã«ããã«ã¢
ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâãšãã«ã¹ã«ããã«ã¢
ããªã³ã ïŒïŒïŒâãžã¡ããã·âïŒâïœâãããã«ã¹ã«ã
ãã«ã¢ããªã³ãå㯠ïŒïŒïŒâãžã¡ããã·âïŒâïœâãããã«ã¹ã«ã
ãã«ã¢ããªã³ã ããåŸãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ¹
æ³ã ïŒïŒ äžè¬åŒïŒïŒïŒ ïŒåŒäžã ïœåã³ïœã¯ããããå¥åã«ïŒãïŒã®å€ã§ããã R3åã³R4ã¯ããããå¥åã«ççŽ æ°ïŒãïŒã®äœ
çŽã¢ã«ãã«åºãè¡šãã R1åã³R2ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºãè¡šã
ããæãã¯çªçŽ ååãšçµåããŠïŒååã¯ïŒåã®çµ
åãæããçªçŽ å«æè€çŽ ç°åŒåºãç¹ã«ççŽ æ°ïŒã
ïŒã®çŽéãããã¯åå²éã¢ã«ãã«åºã«ãã眮æã
ããŠãããæªçœ®æã®ãããªãžããã¢ã«ããªããã
ãã©ãžãã«ããããŒã«ãããã¯ãããªãžãåºã圢
æãã R5ã¯æ°ŽçŽ ååãããã²ã³ååãNO2åºãNH2
åºãCF3åºãççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºåã¯ç
çŽ æ°ïŒãïŒã®ã¢ã«ãã«ã¹ã«ããã«åºãè¡šãã R6åã³R7ã¯ããããå¥åã«æ°ŽçŽ ååãççŽ æ°
ïŒãïŒã®ã¢ã«ãã«åºåã¯ççŽ æ°ïŒãïŒã®ã·ã¯ãã¢
ã«ãã«åºãè¡šãïŒ ãæããååç©äžŠã³ã«ãã®è¬å€äžèš±å®¹ãåŸãå¡©ã®
å°ãªããšãïŒã€ãå«æãã粟ç¥èª¿ç¯äœçšãæãã
è¬å€çµæç©ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8108125A FR2504528A1 (fr) | 1981-04-23 | 1981-04-23 | Dialcoxy (2,4) benzenesulfonamides n-substitues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57181053A JPS57181053A (en) | 1982-11-08 |
| JPH0153669B2 true JPH0153669B2 (ja) | 1989-11-15 |
Family
ID=9257710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57068566A Granted JPS57181053A (en) | 1981-04-23 | 1982-04-23 | N-substituted 2,4-dialkoxybenzene sulfonamide |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0064445B1 (ja) |
| JP (1) | JPS57181053A (ja) |
| AT (1) | ATE9996T1 (ja) |
| CA (1) | CA1196919A (ja) |
| DE (1) | DE3261038D1 (ja) |
| DK (1) | DK178782A (ja) |
| ES (1) | ES8306107A1 (ja) |
| FR (1) | FR2504528A1 (ja) |
| IE (1) | IE52855B1 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3363289D1 (de) * | 1982-09-28 | 1986-06-05 | Beecham Wuelfing Gmbh & Co Kg | Sulfon amides |
| JPS5976051A (ja) * | 1982-10-21 | 1984-04-28 | Tanabe Seiyaku Co Ltd | ããã¿ã¬ã³èªå°äœããã®è£œæ³åã³è©²èªå°äœãçšããå åŠçŽåºŠæ€å®è©Šè¬ |
| FR2553409B1 (fr) * | 1983-10-18 | 1986-04-18 | Choay Sa | Nouveaux benzenesulfonyl-lactames, leur procede de preparation et leur application comme substance active de compositions pharmaceutiques |
| FR2598412B1 (fr) * | 1986-03-12 | 1988-10-21 | Sanofi Sa | Nouveaux derives de diarylcetones et leurs procedes de preparation et les compositions pharmaceutiques les contenant |
| KR100262419B1 (ko) * | 1993-06-23 | 2000-09-01 | ëê°ìŒë§ ì€ì¬ë¬Ž | ííì± ì§íì ì ì©í ë²€ì ì ë첎 |
| EP0883613A1 (en) * | 1996-02-09 | 1998-12-16 | Smithkline Beecham Plc | Sulfonamide derivatives as 5ht7 receptor antagonists |
| EP0912550A1 (en) * | 1996-06-25 | 1999-05-06 | Smithkline Beecham Plc | Sulfonamide derivatives as 5ht7 receptor antagonists |
| ES2161594B1 (es) * | 1998-12-17 | 2003-04-01 | Servier Lab | Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
| SK542007A3 (sk) * | 2007-04-20 | 2008-11-06 | Unimed Pharma, Spol. S R. O. | Substituované sulfónamidy, spÃŽsob ich prÃpravy, farmaceutickÃœ prostriedok s ich obsahom a ich pouÅŸitie |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB667772A (en) * | 1947-11-28 | 1952-03-05 | Gen Aniline & Film Corp | Monosulfonamide derivatives of resorcinol |
| DE2128011A1 (de) * | 1971-06-05 | 1972-12-14 | Cassella Farbwerke Mainkur AG, 6000 Frankfurt-Fechenheim | Neue Sulfonyl verbindungen und Verfahren zu ihrer Herstellung |
| FR2313918A1 (fr) * | 1975-06-09 | 1977-01-07 | Choay Sa | Methoxy-2 benzenesulfonamides n-substitues, procede pour les preparer et medicaments les contenant |
-
1981
- 1981-04-23 FR FR8108125A patent/FR2504528A1/fr active Granted
-
1982
- 1982-04-20 IE IE925/82A patent/IE52855B1/en unknown
- 1982-04-21 CA CA000401378A patent/CA1196919A/en not_active Expired
- 1982-04-21 AT AT82400717T patent/ATE9996T1/de active
- 1982-04-21 DE DE8282400717T patent/DE3261038D1/de not_active Expired
- 1982-04-21 EP EP82400717A patent/EP0064445B1/fr not_active Expired
- 1982-04-22 ES ES511609A patent/ES8306107A1/es not_active Expired
- 1982-04-22 DK DK178782A patent/DK178782A/da not_active Application Discontinuation
- 1982-04-23 JP JP57068566A patent/JPS57181053A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2504528B1 (ja) | 1984-05-11 |
| FR2504528A1 (fr) | 1982-10-29 |
| ES511609A0 (es) | 1983-06-01 |
| DE3261038D1 (de) | 1984-11-29 |
| JPS57181053A (en) | 1982-11-08 |
| CA1196919A (en) | 1985-11-19 |
| EP0064445B1 (fr) | 1984-10-24 |
| IE52855B1 (en) | 1988-03-30 |
| EP0064445A1 (fr) | 1982-11-10 |
| ES8306107A1 (es) | 1983-06-01 |
| DK178782A (da) | 1982-10-24 |
| ATE9996T1 (de) | 1984-11-15 |
| IE820925L (en) | 1982-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3454554A (en) | Aminoalkyliminodibenzyl compounds | |
| KR0174752B1 (ko) | ìŽíì í€í ë¡í íšì ì í°ì믞ë ì ë첎 ë° ê·ž ì ì¡°ë°©ë² | |
| TWI234558B (en) | Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them | |
| O'Brien et al. | Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo | |
| HUT65489A (en) | Process for producing of indole derivatives and pharmaceutical compositions comprising them | |
| US5164397A (en) | 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in urinary therapeutics | |
| EP0132764B1 (en) | Derivatives of dihydrodibenzocycloheptylidene-ethylamine | |
| US6028081A (en) | Substituted quinolone derivatives and pharmaceuticals containing the same | |
| CZ285850B6 (cs) | 2-Aminoindany jako selektivnà dopaminové D3 ligandy | |
| JPH0153669B2 (ja) | ||
| US4002623A (en) | Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines | |
| US4328155A (en) | Meta-sulfonamido-benzamides | |
| PT1546119E (pt) | Processo para a preparação de 4-(3'-cloro-4'-fluoroanilino)-7- metoxi-6-(3-morfolinopropoxi)quinazolina | |
| IE913175A1 (en) | Aryl-fused and hetaryl-fused-2, 4-diazepine and 2,¹4-diazocine antiarrhythmic agents | |
| US4714700A (en) | N-substituted 2,4-dialkoxy benzenesulfonamides and pharmaceutical compositions | |
| US4457875A (en) | Substituted 2,4 dialkoxy benzene sulfonyl chlorides | |
| KR20030024919A (ko) | -(3,5-ëíŽë¡ë¡-2-ë©í¡ìíë)-4-ë©í¡ì-3-íŒíëŒì§-1-ìŒ-ë²€ì ì í°ì믞ë | |
| CZ325196A3 (en) | Derivatives of hydroximic acid, pharmaceutical compositions containing thereof, process of their preparation and intermediates used in the preparation process | |
| JPH05117243A (ja) | ïŒâã¢ããããªããžã³âïŒâã«ã«ãããµããèªå°äœããã®è£œé ãšæ²»çã«ãããå¿çš | |
| CA1094070A (en) | 1-phenyl-piperazine derivatives | |
| EP0585116B1 (en) | 1-Alkoxy-naphthalene-2-carboxamide derivatives with high affinity for the serotonin 5-HT1A receptor | |
| US3954763A (en) | N-Metatrifluoromethylthiophenyl-piperazine | |
| MXPA01008860A (es) | Derivados de fenoxifenilheterociclilo como inhibidores selectivos de la recaptacion de serotonina. | |
| EP0294615B1 (en) | Cyclobutene-3,4-dione-intermediates and their use in the preparation of histamine h2-antagonists | |
| US4059584A (en) | 2-Acylamino-3-[3-(dialkylamino)propyl]imidazo[4,5-b]pyridines |